Complexes in Asymmetric Synthesis The Use of N,P-Iridium ...1169503/FULLTEXT01.pdf · This thesis...
Transcript of Complexes in Asymmetric Synthesis The Use of N,P-Iridium ...1169503/FULLTEXT01.pdf · This thesis...
The Use of N,P-Iridium and N,P-PalladiumComplexes in Asymmetric SynthesisWangchuk Rabten
Academic dissertation for the Degree of Doctor of Philosophy in Organic Chemistry atStockholm University to be publicly defended on Wednesday 31 January 2018 at 10.00 inMagnélisalen, Kemiska övningslaboratoriet, Svante Arrhenius väg 16 B.
AbstractThe work presented in this thesis concerns asymmetric catalysis using chiral N,P-ligands and iridium or palladiumtransition metals. The first part (Chapters 2 and 3) highlights the N,P-iridium catalyzed asymmetric hydrogenation of 1,4-cyclohexadienes having functionalized or unfunctionalized substituents, including allylsilane side chains. A series of N,P-iridium catalysts were synthesized and screened on a number of cyclohexadienes. The developed N,P-iridium catalystshave provided excellent chemo-, regio- and enantioselectivity for most of the products obtained. For substrates havingan allylsilane sidechain, the chiral cyclic allylsilane products were used to induce stereocontrol in a subsequent Hosomi-Sakurai reaction using TiCl4 as Lewis acid and aldehydes as electrophiles. The corresponding homoallylic alcohols wereobtained in good to excellent diastereoselectivity.
The second part (Chapter 4) describes the N,P-iridium catalyzed asymmetric hydrogenation of various vinyl fluorides.A number of tri- and tetrasubstituted vinyl fluorides were synthesized and evaluated for the asymmetric hydrogenation.The corresponding saturated chiral fluoro compounds were obtained in very high enantioselectivity (up to 99% ee). Thedefluorination, usually known to occur under the catalytic hydrogenation conditions, were not observed for the majorityof the substrates.
Finally, Chapter 5 describes the application of N,P-ligands in the asymmetric cycloisomerization of 1,6-enynes using apalladium precatalyst. The enantioselectivities for the products were found to depend both on the substrate as well as thehydrogen source. These developed catalytic reactions provide attractive methods to create multiple stereogenic centers ina molecule in relatively few steps from readily available starting materials.
Keywords: Iridium, Asymmetric Hydrogenation, Palladium, Asymmetric Cycloisomerization and Hosomi-SakuraiAllylation.
Stockholm 2018http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-150602
ISBN 978-91-7797-061-3ISBN 978-91-7797-062-0
Department of Organic Chemistry
Stockholm University, 106 91 Stockholm
TheUseofN,P-IridiumandN,P-PalladiumComplexesinAsymmetricSynthesis
WangchukRabten
ii
© Wangchuk Rabten, Stockholm 2018 Cover picture: By Umaporn Sratongyung ISBN: 978-91-7797-061-3 Printed in Sweden by Eprint, Stockholm 2018 Distributor: Department of Organic Chemistry, Stockholm University
iii
DedicatedtomylatefatherRinzinandtomymotherPemaDema
iv
v
Abstract
Thework presented in this thesis concerns asymmetric catalysis using chiralN,P-ligandsandiridiumorpalladiumtransitionmetals.Thefirstpart(Chapters2and3)highlightstheN,P-iridiumcatalyzedasymmetrichydrogenationof1,4-cyclohexadienes having functionalized or unfunctionalized substituents,including allylsilane side chains. A series of N,P-iridium catalysts weresynthesized and screened on a number of cyclohexadienes. The developedN,P-iridium catalysts have provided excellent chemo-, regio- andenantioselectivityformostoftheproductsobtained.Forsubstrateshavinganallylsilanesidechain, thechiralcyclicallylsilaneproductswereusedto inducestereocontrol in a subsequent Hosomi-Sakurai reaction using TiCl4as Lewisacid and aldehydes as electrophiles. The corresponding homoallylic alcoholswereobtainedingoodtoexcellentdiastereoselectivity.The second part (Chapter 4) describes the N,P-iridium catalyzed asymmetrichydrogenationofvariousvinylfluorides.Anumberoftri-andtetrasubstitutedvinyl fluorides were synthesized and evaluated for the asymmetrichydrogenation. The corresponding saturated chiral fluoro compounds wereobtained in very high enantioselectivity (up to 99% ee). The defluorination,usuallyknowntooccurunderthecatalytichydrogenationconditions,werenotobservedforthemajorityofthesubstrates.Finally, Chapter 5 describes the application ofN,P-ligands in the asymmetriccycloisomerization of 1,6-enynes using a palladium precatalyst. Theenantioselectivities for the products were found to depend both on thesubstrateaswellasthehydrogensource.Thesedevelopedcatalyticreactionsprovide attractive methods to create multiple stereogenic centers in amoleculeinrelativelyfewstepsfromreadilyavailablestartingmaterials.
vi
Listofpublications
This thesis is based entirely on the following papers, which will bereferredtoby theirRomannumerals I-IV.Reprintsof thearticlesweremade with the kind permission of the publishers. The author hasclarifiedcontributionforeachpublicationinAppendixA.
I. Enantio-andRegioselectiveIr-CatalyzedHydrogenationofDi-andTrisubstitutedCycloalkenesByronK.Peters,†JianguoLiu,†CristianaMargarita,†WangchukRabten,†SutthichatKerdphon,†AlexanderOrebom,ThomasMorsch,andPherG.Andersson*J.Am.Chem.Soc.,2016,138,11930-11935.
II. Ir-Catalyzed Asymmetric and Regioselective Hydrogenation ofCyclicAllylsilanesandGenerationofQuaternaryStereocentersviatheHosomi-SakuraiAllylationWangchuk Rabten, CristianaMargarita, Lars Eriksson and Pher G.Andersson*Chemistry–AEuropeanJournal,DOI:10.1002/chem.201704684. InpressHOTPAPER
III. N,P-Iridium Catalyzed Asymmetric Hydrogenation of VinylFluoridesWangchukRabten†,SudiptaPonra†,SutthichatKerdphon,HaiboWuandPherG.Andersson*Manuscriptinpreparation
IV. Thiazole, Imidazole and Oxazoline Based N,P-Ligands forPalladium-CatalyzedCycloisomerizationof1,6EnynesXuQuan,JianguoLiu,WangchukRabten,SimoneDiomedi,ThishanaSingh,andPherG.Andersson*Eur.J.Org.Chem.,2016,3427-3433
†Authorscontributedequallytothiswork.
Publicationnotincludedinthisthesis:
vii
I. Catalytic Water Oxidation by a Molecular Ruthenium Complex:
UnexpectedGenerationofaSingle-SiteWaterOxidationCatalystWangchuk Rabten, Markus D. Kärkäs,* Torbjörn Åkermark, HongChen, Rong-Zhen Liao, Fredrik Tinnis, Junliang Sun, Per E. M.Siegbahn,PherG.Andersson,*andBjörnÅkermark*Inorg.Chem.,2015,54,4611-4620
II. ARutheniumWaterOxidationCatalystBasedonCarboxamideLigandWangchukRabten,TorbjörnÅkermark,MarkusD.Kärkäs*,HongChen,JunliangSun,PherG.Andersson*,andBjörnÅkermark*DaltonTrans.,2016,45,3272-3276
III. Catalyst–Solvent Interactions in a Dinuclear Ru-based WaterOxidationCatalystAndreyShatskiy,ReinerLomoth,AhmedF.Abdel-Magied,WangchukRabten,TanjaM.Laine,HongChen,JunliangSun,PherG.Andersson,MarkusD.Kärkäs,*EricV.Johnston*andBjörnÅkermark*DaltonTrans.,2016,45,19024-19033
IV. An Enantioselective Approach to the Preparation of ChiralSulfonesbyIr-CatalyzedAsymmetricHydrogenationByron K. Peters, Taigang Zhou, Janjira Rujirawanich, Alban Cadu,ThishanaSingh,WangchukRabten, SutthichatKerdphon,andPherG.Andersson*J.Am.Chem.Soc.,2014,136,16557-16562
viii
Contents
Abstract v
Listofpublications vi
Contents viii
Abbreviations x
1 Introduction 11.1 Chirality...............................................................................................................11.2 Chiralresolutionofracemicmixtures....................................................21.3 Asymmetricsynthesis....................................................................................3
1.3.1 Chiralpoolmethod........................................................................................31.3.2 Chiralauxiliarymethod..............................................................................41.3.3 Asymmetriccatalysis...................................................................................5
1.4 Aimsofthisthesis..........................................................................................11
2 Enantio- and Regioselective Hydrogenation of Di- andTrisubstituted1,4-Cyclohexadienes(PaperI) 122.1 Introduction.....................................................................................................122.2 Resultsanddiscussion................................................................................13
2.2.1 Substratessynthesis..................................................................................132.2.2 Catalystscreening.......................................................................................142.2.3 Regioselectivity............................................................................................20
2.3 Conclusion........................................................................................................21
3 Ir-Catalyzed Asymmetric and Regioselective Hydrogenation ofCyclic Allylsilanes. Generation of Quaternary Stereocenters via theHosomi-SakuraiAllylation(PaperII) 223.1 Introduction.....................................................................................................223.2 Hosomi-Sakuraireactionusingcyclicallylsilane.............................22
3.2.1 MechanismoftheHosomi-Sakuraiallylation.................................243.3 Resultsanddiscussion................................................................................25
3.3.1 Synthesisofchiralcyclicallylsilane....................................................253.3.2 Optimizationoftheasymmetricmono-hydrogenation.............26
ix
3.3.3 DiastereoselectiveHosomi-Sakuraiallylation...............................293.4 Conclusion........................................................................................................35
4 N,P-Iridium Catalyzed Asymmetric Hydrogenation ofVinylfluorides 364.1 Introduction.....................................................................................................364.2 Substratesynthesis.......................................................................................384.3 Resultsanddiscussion................................................................................394.4 Determinationofabsoluteconfiguration............................................444.5 Conclusion........................................................................................................46
5 Palladium-CatalyzedCycloisomerizationof1,6-Enynes(PaperIII) 475.1 Introduction.....................................................................................................47
5.1.1 Palladiumcatalyzedcycloisomerization..........................................475.1.2 Mechanismofpalladiumcatalyzedcycloisomerization............49
5.2 Resultsanddiscussion................................................................................515.2.1 Substratescope............................................................................................525.2.2 Investigationofthehydrogensource................................................54
5.3 Enantioselectivityandabsoluteconfiguration.................................555.4 Conclusion........................................................................................................56
6 PopulärvetenskapligSammanfattningpåSvenska 57
AppendixA:Contributionlist 58
Acknowledgements 59
References 61
x
Abbreviations
* StereogeniccentreAc AcetylAr AromaticAx ChiralauxiliaryBArF- Tetrakis[3,5-bis(trifluoromethyl)phenyl]borateCat. CatalystCOD 1,5-CyclooctadieneConv. ConversionCy Cyclohexyldba DibenzylideneacetoneDIBAL DiisobutylaluminiumhydrideDMF DimethylformamideDMSO DimethylsulfoxideDNA DeoxyribonucleicacidDTBB 4,4’-Di-tert-butylbiphenylDCA Dichloroaceticaciddr Diastereomericratio ee EnantiomericexcessE Electrophileequiv EquivalentEt EthylEWG ElectronwithdrawinggroupEDG ElectrondonatinggroupGC GasChromatographyh Hour(s)Het HeterocycleHPLC HighPerformanceLiquidChromatographyinv InvertIPA Isopropylalcoholi-Pr Isopropyli-Bu Isobutyl
xi
K RateconstantL LigandLA LewisacidM MolarMe MethylMS Molecularsievem MetaNFSI N-FluorobenzenesulfonimideNMR NuclearMagneticResonancen-Bu NormalButyln-BuLi n-Butyllithiumn-Hex n-Hexylo Orthoo.n. OvernightOct Octylo-Tol ortho-Tolylp ParaPh PhenylPNB p-NitrobenzylPVP Poly(4-vinylpyridine)PHOX Phosphine-OxazolinePy PyridinePF6- Hexafluorophosphater.t. Roomtemperaturerac RacemicSFC SupercriticalFluidChromatographyt-BDMS tert-Butyldimethylsilylt-Bu tert-Butylt-BuOH tert-ButanolTFA TrifluoroaceticacidTHF TetrahydrofuranTMS TrimethylsilylTs TosylTS TransitionstateTBAF Tetra-n-butylammoniumfluoride
1
1 Introduction
1.1 Chirality
The term “chirality”was derived from theGreekword “χειρ” (kheir)[1],whichmeanshand, and it therefore indicates thehandednessof anobject.Our leftandrighthandsareindeedasimpleexampleofchirality,beingmirrorimagestooneanother,butnotsuperimposable.Likewise,moleculesaresaidtobechiralifthecompoundpossessesstereogenicelements,likestereogeniccentersthatarisewhendifferent substituents on an atomwith the same connectivity butarearrangeddifferently in three-dimensionalspace (Figure1.1).Thepresenceof stereogenic centers gives rise to different types of stereoisomers, namelyenantiomersanddiastereoisomers.
Figure1.1Simplerepresentationofchiralmolecule.
Enantiomers are a pair of stereoisomeric compounds, which are non-superimposablemirrorimagesofoneanother.Enantiomersarealsoreferredtoasopticalisomers,duetotheirabilitytorotatetheplaneofpolarizedlightandthey essentially display identical physicochemical properties, for examplemelting points, solubility and it is fairly difficult to separate them byconventionalmethods.[2]Ontheotherhand,diastereoisomericcompoundsarenot mirror images of one another and have significantly different physicalproperties,thustheycanbeseparatephysically.At the molecular level, biological systems are made of macromolecules likeproteins,polynucleotides (DNA),andglycolipids,which in turnaremade from
!
⍺
"##
"
⍺
!
Mirror
#"
⍺
! !
⍺
"#
Cannot besuperimposed
2
chiralbuildingblocks(L-aminoacidsandD-carbohydrates).Inthedevelopmentof drugs, in the pharmaceutical industry, the importance and need forevaluation of individual enantiomers have become evenmore crucial. This isbecause their interaction with chiral receptors such as enzyme and proteinsexhibitdifferentpharmacologicalactivitiesandpharmacokineticsproperties.[3]Oneoftheinfamousexamplesthatlaterleadtodevelopmentofsingleisomerdrugs is the thalidomide tragedy (Figure 1.2a).[4] The (R)-thalidomide hassedative properties, while the (S)-thalidomide causes severe birth defects.However, the tragedy in the early 1960swould not have been avoided if thedrughadbeenusedasasingleisomersincethedrugracemizesduringuptakein the body.[5] In the same way, the two enantiomers of ethambutol actdifferently (Figure 1.2b). (S,S)-(+)-ethambutol is used for the treatment oftuberculosis, but on other hand (R,R)-(-)-ethambutol causes blindness.[6] As aresultofthedifferentpharmacologicalactivityshownbyoppositeenantiomers,theuseofsingleenantiomericdrugshasincreaseddrastically.Thus,developingstereoselectivemethodsthatprepareexclusivelyonesingleenantiomerwouldbe themethodof choice. Thereare twowell-knownmethodologies toobtainsingleenantiomers;chiralresolutionandasymmetricsynthesis.
Figure1.2Examplesofdrugswithdifferentpharmacologicalactivities.
1.2 Chiralresolutionofracemicmixtures
Chiral resolution is the process for producing optically pure chiral moleculesfromracemicmixturesbycreatingandiastereomericenvironment.[7]Basedonthe separation method, chiral resolution can be divided into numerouscategories.Resolutionbydiastereomerformationconsistsof thetreatmentofthe racemic mixture with an optically active reagent to form diastereomericsalts. Due to their significant difference in physical properties, those cansometimesbeseparatedbyrecrystallizationorbycolumnchromatography.Kinetic resolution relies on the different rate of the reaction of twoenantiomers with a chiral reagent; the enantiomer that reacts faster will be
NNH
O
OO
O
NNH
O
OO
O
(R)-thalidomide (S)-thalidomide
HN
NH
OH
HO
(S,S)-(+)-ethambutol
HN
NH
OH
HO
(R,R)-(-)-ethambutol
a b
3
convertedtotheproductwhiletheunreactive(slower)enantiomerwillbeleftin the solution. To achieve kinetic resolution, the difference in reaction ratebetween the two enantiomersmust be significantly large. A racemicmixturecan also be separated by chiral chromatography. However these methodsmentioned above cannever be able to achieve amaximumyield higher than50%.Analternative tokinetic resolutionwouldbedynamickinetic resolution;the process that combines racemization and resolution (Figure 1.3). Theunreactive or mismatched enantiomer in the racemic mixture is rapidlyconverted to the faster reacting enantiomer by a catalyst and sequentiallyconsumed in the conversion to product. The process continues until bothenantiomersarecompletelyconsumed,thusintheoryitcanbeabletodeliver100%yield.
Figure1.3Principlesofdynamickineticresolution.
1.3 Asymmetricsynthesis
Asymmetricsynthesis is thepreparationofopticallyactivemoleculesbychiralinductiononanachiralsubstratethroughchiraltransferfrompre-existingchiralmolecules.Itcanbedividedintoseveralcategories:
• Chiralpoolmethod• Chiralauxiliarymethod• Asymmetriccatalysis
1.3.1 Chiralpoolmethod
Thechiralpoolmethodusesnaturallyoccurringchiralmaterialssuchasaminoacids, carbohydrates and terpenes to make an enantiomerically purecompounds.Forexample,thedrugPrimaxinwhichisusedforthetreatmentofbacterial infections was synthesized using aspartic acid as a chiral startingmaterial(Figure1.4).[8]Thenaturallyoccurringchiralmoleculescanprovideanoptical purity up to 100%, however their scarcity, availability in only one
SS
PR
PSSlow
kB
Fast
kA
Racemizationkinv
kinv-1 SR, SS : Substrate enantiomersPR, PS : Product enantiomers
SR
X
4
enantiomeric form and tedious extraction from nature makes them moredifficulttoaccess.
Figure1.4SyntheticrouteforthedrugPrimaxinstartingfromasparticacid.
1.3.2 Chiralauxiliarymethod
Chiralauxiliariesareopticallypurecompoundsthatcanbetemporarilyinstalledon the substrate to direct the stereochemical outcome of a reaction (Figure1.5).[9]Thechiralauxiliarycancomeeitherfromnaturalsource(chiralpool)orsynthetic.Normallythesubstratesrequirescertainfunctionalgroupsinordertoselectively attach to the auxiliary.[10] This unit is installed on the substratesbefore the stereoselective reaction and then removed later in the synthesis.The use of stoichiometric chiral auxiliary adds two additional steps, additionandremoval,whichmakethismethodlessefficientforthechemicalsynthesisofenantiomericallypurematerials.
Figure1.5Diastereoselectivesynthesiswithchiralauxiliaries.
HO2CNH2
CO2H
NO
CO2H
H NO
CO2H
H
OH
NO
OAc
H
OH
NO
OAc
H
Ot-BDMS OSiMe3
N2
CO2PNB1. Lewis acid2. H+
TolueneN
O H
OH
O
N2
CO2PNB+
Rh(Oct)2MeOAc
NO
OH
O
CO2PNB
NO
OH
S
CO2H
H H HNNH
L-aspartic acid
Imipenem (Primaxin®)
O
OHR Introduction
of the auxiliary
O
AxR Diastereo-
selective reaction
*O
AxR
E
*O
OHR
EHydrolysis
Ax = Chiral auxiliary Auxiliary recycle
Ax H
5
1.3.3 Asymmetriccatalysis
In asymmetric catalysis chiral compounds are generated through asymmetricinductionusingachiralcatalyst.Acatalystisaspeciesthatenhancestherateofchemical reaction by lowering the activation energy.[11] In the process thecatalyst is neither consumed nor destroyed, therefore sub-stoichiometricamounts(frequentlylessthan1mol%)issufficienttocatalyzethebulkreaction.Theuseofacatalystoftenfacilitatestheisolationofaproduct,sincetherearenotmanyunwantedbyproducts tobe removedat theendof a reaction; it isthus an atom economical, environmental friendly and cost effective strategy.Oneofthemostfrequentlyusedreactionsinasymmetriccatalysisinvolvestheasymmetricreductionofprochiralcarbon(C=O,C=C,C=N).(Figure1.6).[12]
Figure1.6Genericexamplesofcatalyticasymmetricsynthesis.
1.3.3.1 Asymmetrichydrogenationofolefins
The asymmetric hydrogenation of an alkene to an alkane by usinghomogeneous transitionmetal catalysts has been one of themost successfulandwell-studiedmethodologies inacademiaaswellas industries,[13]owing toits straightforward strategy to access enantiomerically pure moleculesemploying a relatively inexpensive and environmentally benign reductant(hydrogen). More importantly, the successes in academic research onasymmetric hydrogenation was often complemented with industrialapplications,whichinturndrawsmoreinterestinthisfield.[14]Thehomogeneouscatalytichydrogenationofsimpleolefinswasfirstdisclosedin1965byWilkinsonandco-workersusingtherhodium(Rh(PPh3)3Cl)catalystinorganic solvent.[15] This laid the foundation for the development of chiralanalogs for an asymmetric induction. In 1968 the groups of Knowles[16] andHorner[17] reported independently on the asymmetric hydrogenation of an
R′O
R
R′
R
R′
R
R′
R
R′N
R
R′
R
H2
Catalyst
H
OH
R′′′
R′′
R′′′
R′′H2
Catalyst
R′′NH
HR′′
H2
Catalyst
HH reduction of alkenes
reduction of prochiral ketones
reduction of prochiral imine
6
olefin using chiral phosphine ligands in presence of the Rh metal precursor(Figure1.7).
Figure 1.7 Earlier work by the group of Knowles (a) and Horner (b) on asymmetrichydrogenationofolefins.
However,thelevelofasymmetric inductionwas low,affordingonly15%eeofthe hydrogenated product. Thereafter, a series of chiral monodentatephosphineligands[18](PAMP,CAMP)weredevelopedwhichleadtoanincreasedlevelofenantioselectivity,resultingin88%eeintheasymmetrichydrogenationofα-acetamidocinnamicacid.Despitethesuccesswithmonodentatephosphineligands, the focuswas slowly diverted towards the development of bidentatephosphine ligands. The chiral bidentate phosphine ligands DIOP[19] DIPAMP[20]BINAP[21]weresuccessfullydevelopedandappliedinasymmetrichydrogenationofα-acetamidocinnamicacidusingaRhpre-catalyst(Figure1.8).Highcatalyticreactivityandhighenantioselectivitywereobserved.TheRu-BINAPcatalystwasalso found useful for asymmetric hydrogenation of unsaturated carboxylicacid.[3a, 21] Almost all the reported asymmetric hydrogenations were mainlybased on Rh and Ru catalyst and also limited to substrates containingfunctionalitiesthatcouldformachelatewiththemetalcatalyst.
HOOCCOOH
RhCl3L3*
HOOCCOOHH2
OMePh
[Rh-(1,5 hexadiene)Cl]2, L
H2*OMePh
(a) Knowles and Sabacky
(b) Horner and co-workers
P*i-PrL =
P*n-Pr
L =
up to 8% ee
up to 15% ee
7
Figure 1.8 The chiralmonoandbidentatephosphine ligands and their comparison inasymmetrichydrogenationofα-acetamidocinnamicacid.
Thehydrogenationofunfunctionalizedolefinswasnotamainfocusyet,duetotheirpoorreactivityandenantioselectivity.In1977Crabtreeandco-workers[22]reported the iridium [Ir(COD)(PCy3)(Py)]+PF6- (Figure 1.9b) catalyzedhydrogenation of unfunctionalized olefins. They noticed that a smallmodification of theOsborn iridium complex (Figure 1.9a),[23] by replacing thetriphenylphosphine groups with pyridine and a tricyclohexylphosphine group,andconductingthereaction inpoorlyorweaklycoordinatingsolvents(CH2Cl2,CHCl3orchlorobenzene)increasedthecatalyticefficacy.Itwasbyfarthemostactivehomogeneoushydrogenationcatalystatthattime.In1997Pfaltzandco-workersintroducedtheasymmetricversionoftheiridiumcatalystbyreplacingCrabtree’spyridineandphosphine ligandswith thechiralbidentate N,P-ligand (PHOX) (Figure 1.9c). This ligand was then used forasymmetrichydrogenationoftheiminesandunfunctionalizedolefins.[24]Later,theyalsoobserved that thebulkyandweakly coordinatingBArF-counteranionincreased the reactivity and stability of the catalyst. Since then, many chiralN,P-ligands has been reported and successfully applied in the asymmetrichydrogenationofolefins.[25]
OH
O
NHAc
* OH
O
NHAc
Rh-phosphine catalyst,H2
OMeP
Ph
OMeP
Cy
PAMP CAMP
PPh2
PPh2O
O
DIOP
PMeO P OMePPh2PPh2
DIPAMP BINAP
50-60% ee 80-88% ee 72% ee 95% ee 84% ee
8
Figure1.9Developmentofnon-functionalizedolefinshydrogenationcatalysts.
The mechanistic understanding of the N,P-iridium catalyzed asymmetrichydrogenationofolefinshasbeen fully investigatedby various groups. Itwasproposedtooccureithervia IrI/IrIII[26]or IrIII/IrV[27]catalyticcycles(Figure1.10).Whilebothcatalyticcyclesproceedthroughintermediate3,whichisgeneratedupon the addition of hydrogen to the iridium metal precursor 1, the onlydifferenceliesinthenumberofhydridesboundtothemetalinthekeyreactiveintermediates 4 and 7. From the recent low temperature NMR experimentalstudiesby thePfaltz group,[28] itwaspossible to identify and characterize theiridium dihydride alkene complexe 10. They described the dihydride as acatalyticallycompetent intermediate,and it representtherestingstageof thecatalytic cycle. Addition of onemolecule of hydrogen is required in order toproceed in the catalytic cycle. This experiment demonstrates that the IrIII/IrVcatalyticcyclesproposedbytheAnderssonandBurgessgroupsismostlikelytooperate. The olefin undergoes migratory insertion of hydride trans to thedihydrogen together with oxidative addition of the dihydrogen to giveintermediate 5, which upon reductive elimination gives 6 and finallydisplacementofthealkaneproductwithtwomoleculesofsolventregeneratesthecatalyst.
IrIPPh3Ph3P
Cl
IrIPCy3Py PF6
O
N
P IrPh
Ph BArF
(a) Osborn’s catalyst (b) Crabtree’s catalyst
(c) Pfaltz’s catalyst
B
CF3F3C
CF3
CF3
CF3F3C
F3C
F3CNa
NaBArF
9
Figure 1.10 Proposed Ir(I)/Ir(III) and Ir(III)/Ir(V) catalytic pathways for the iridiumcatalyzedhydrogenation.
Based on the mechanistic studies carried out by the Andersson group,[29] aselectivitymodel for theN,P-iridium catalyzed asymmetric hydrogenation hasbeen developed that can predict the absolute configuration of thehydrogenated products. The model basically describes the steric hindranceimposedby theN,P ligandwhere theolefincoordinate iridium.Dependingonthe level of steric bulk of the iridium catalyst, this area is divided into fourquadrants (i, ii, iii and iv) (Figure 1.11). Thequadrant that is occupiedby thephenylringfromtheligandisassignedasthemosthinderedquadrant(IforR-cat.and iii forS-cat.).Oneofthephenylgroupsonthephosphorousoccupiespartially the other quadrant,which is assigned as semi-hindered quadrant (ivforR-cat. and ii for S-cat.). The other two quadrants are left relatively open.Placing the olefin vertically (energetically favored) and trans to thephosphorousatominawaythatthesmallestsubstituent(H)occupiesthemosthinderedquadrant (I forR-cat. and iii forS-cat.) toavoid steric repulsionand
IrI
PNIrIII
H
PNHH2
2H2 + 2S
IrIII
HS
PNH
S
1 2 3
IrV
HH
PNH
H
IrIII
HS
PNH
S
IrIII
H
PNH
IrIII
HH
PNH
H
IrIII
H
PNH
S
IrIII
H
PNH
S
IrI
SS
PN 2S
HHH2
HH
SH2
2SS
H H
IrIII/IrVIrI/IrIII
S
3
4
5
6
7
8
9
IrIII
H
PNH
10
10
results in a favored configuration. Thus the addition of the hydride from thefaceofiridiummetaldeterminestheabsoluteconfiguration.
Figure 1.11Use of the selectivitymodel to predict the absolute configuration of thehydrogenatedproduct.
PN
i ii
iii iv
IrN
N P
i ii
iii iv
Ir
N
N
N
PIr
PN
N
i ii
iii iv
i ii
iii iv
Sterically favored
Sterically unfavored
Ir
(R)
(S)
N P
i ii
iii iv
Ir
N
Sterically favored
N
N
P
N
N
P
H
H
H
H
H(R)
H
(S)
11
1.4 Aimsofthisthesis
Theaimsoftheworkpresentedinthisthesisfocusesonthedevelopmentandfine-tuning of the N,P-ligands structure to enhance catalytic reactivity andenantioselectivity. The application of the N,P-iridium catalyzed asymmetrichydrogenationof variousolefins including substrates containing acid-sensitivefunctionalgroups,aswellasregioselectivemono-hydrogenationsarediscussed.The Ir-catalyzed asymmetric hydrogenation of cyclic molecules such ascyclohexanes to introduce multiple stereocenters is a difficult task and alsointriguingas it is found inmanynaturalcompounds. Theregioselectivemonohydrogenationofadieneisanotherchallengingreaction,asitrequiresasystemthat selectively can hydrogenate one olefin over another. Thus objectives ofthis thesis includemultiple aspects of (chemo-, regio- and enantio-) selectivehydrogenation as well using this stereocontrol for further chemicaltransformations. Finally, the application of the N,P-ligands in the palladiumcatalyzedcycloisomerizationofenynesarealsoinvestigated.
12
2 Enantio-andRegioselectiveHydrogenationofDi-andTrisubstituted1,4Cyclohexadienes(PaperI)
2.1 Introduction
Cyclohexane rings are frequently found in nature[30] and are often used asbuildingblocksforthetotalsynthesisofmanynaturalproducts.[31]Themajorityofthesenaturalproductscontainsstereogeniccentersonthecyclohexanering,forexampleβ-Santonin,[31c]Occidentalol[31b]and(+)-Lycorine (Figure2.1).[32]Thedevelopmentofstereoselectivesynthesesofenantioenrichedcyclohexaneshasthereforebeenanimportantandlongstandinggoalinorganicsynthesis.
Figure2.1Chiralcyclohexanesinnature.
Althoughtherearemanysuccessfulmethodsreportedintheliteratureforthepreparation of cyclohexanes bearing chiral centers,[33] the majority of thesereactions uses chiral reagents or chiral auxiliary in stoichiometric. Thecombination of the Birch reduction and N,P-iridium catalyzed asymmetrichydrogenation provides a new and complementary approach to access chiralcyclohexanesundermild reaction conditions and lowcatalyst loading (0.5-1.0mol%). In 2011, the Andersson group first reported the asymmetrichydrogenationof substituted1,4-cyclohexadienes.[34] In theworkdescribed inthischapter,thefocushasbeenorientedtowardsthedevelopmentofnewandrobustcatalystsforthehydrogenationofsubstratescontainingawiderangeoffunctionalitiesincludingheterocycles(Figure2.2).
OO
OH
⍺-Santonin
OO
OH
!-Santonin
HOH
H
Occidentalol
O
O N
OHHO
H
H
(+)-Lycorine
13
Figure2.2Classesofsubstratesinvestigatedforasymmetrichydrogenation.
2.2 Resultsanddiscussion
2.2.1 Substratesynthesis
The carbocyclic substrates for asymmetric hydrogenation can easily besynthesized from the well known Birch reduction (Scheme 2.1a)[35] of thecorresponding aromatic startingmaterials, using alkalimetals such as sodiumand lithium in presence of liquid ammonia and a proton source (for exampleEtOH, MeOH, and t-BuOH). Co-solvents like THF and diethyl ether are oftenusedtofacilitatethesolubilityofthestartingmaterials.Ingeneral,thereactionissimpleandusuallytheendpointofthesereductionscanbemonitoredbythediscolorationofthedeepbluecolorthatisgeneratedupontheadditionofthealkalimetaltoliquidammonia.IncertaincaseswherethesubstrateisnotsuitableforBirchreduction,duetothe presence of functional groups that can be reduced (such as phenyl,thiophene)thecyclohexadienesubstratescanbepreparedusingtheDiels-Alderreaction(Scheme2.1b).[36]
Scheme2.1Synthesisofsubstrates.
R R
RR
EWG
HetR
Class 1 Class 2 Class 3
Minimally functionalized Functionalized Heterocycle fused
EDG
R1 R2 R1 R2Li/Na
NH3, EtOH R1 R2 R1 R2
+
Birch Diels-Alder
(a) (b)
14
2.2.2 Catalystscreening
Figure2.3Catalystsusedinthisstudy.
Aprofoundeffort has beendedicated to thedevelopmentof awide arrayofN,P-iridium complexes. Tuning the properties of the iridiummetal centers byalteringtheligandstructureandtheelectronicproperties isawell-establishedmethodology to reach themaximum reactivity andattainhigh chemo-, regio-andstereoselectivity.Frompreviousstudiesitwasknownthattheacidityofthehydrogenationcatalystsoftencauseproblemsandmightleadtotheformationofbyproducts.AseriesofN,P-ligandscontainingthebasicimidazolemotifhavebeen successfully synthesized. The reactivity and enantioselectivity of thesecomplexeshavebeenstudiedonthreeselectedmodelssubstrates:monocyclicdihydrobenzene 11a and bicyclic tetrahydronaphthalenes 12a and 13a. TheresultsforthecatalystscreeningareshowninTable2.1.Fullconversiontothedesiredhydrogenatedproductwereobtainedinalmostallcasesusing0.5mol%catalystat50barH2in17h.Althoughthereactivityofthecatalystswerenotaffectedbythesubstitutiononthe imidazole ligands, a strong influence on the enantioselectivity wereobserved.Themethyl substituenton4position (cat. III,entry3)gavea slightimprovement in selectivity compared to cat. II. Changing the position of themethylgroupfrom4to2(cat.IV,entry4),resultedindecreasedselectivityfor
S
N
P Ir
PhPh
N
N
P Ir
PhPh
N
N
P Ir
PhPh
N
N
P Ir
PhPh
N
N
P Ir
PhPh
MeO
OMeN
N
P Ir
PhPh
N
N
P Ir
PhPh
N
N
P Ir
PhPh
IVI II III
V VII VIIIVI
OMe F
O
O
N
P Ir
PhPh
N
S
N
P Ir
PhPh
IX X
B
F3C
F3C
F3C CF3
CF3
CF3
CF3F3C
NaBArF =
BArF BArF
BArF BArF BArF
BArF
BArF
BArFBArFBArF
15
11a, however higher enantioselectivity were observed for the bicyclicsubstrates12a and13a compared to cat. II and cat. III. Replacing themethylsubstituent on position 4 to methoxy (cat. V) or fluoride (cat. VI) groupsresultedin lowerenantioselectivity.Excellentenantioselectivitywereobtainedwithcatalystsbearingtwomethyl (cat.VII,entry7)ortwomethoxy(cat.VIII,entry8)substituentsonpositions2and4.
Table 2.1 Evaluation of catalyst in the asymmetric hydrogenation of unsaturatedcarbocycles.a-c
aReactionconditions:0.25mmolofsubstrate,0.5mol%catalyst,2mLofCH2Cl2,50barof H2, 17 h, r.t. bAll examples are hydrogenated to full conversion whereenantioselectivityisreported,whichwasdeterminedby1HNMRspectroscopy.Nosideproducts were detected. cDetermined by chiral HPLC or GC analyses.dOnly startingmaterialwasdetectedbesidetheproduct.
A series ofminimally functionalized cyclohexadienes (class 1)were evaluatedfor the asymmetric hydrogenation (Table 2.2). The substrates bearing alkylgroupswerehydrogenatedwithcatalystVIIaffordinggoodtoexcellentee'supto99%(entries1-4and14-15).
R3
R2R1
R3
R2R10.5 mol% catalyst
50 bar H2, CH2Cl217 h, r.t.
Ph
Me
Me * Me * i-Bu *
Entry
11a-13a 11b-13b
11b 12b 13b
Conv. ee (%) Conv. ee (%) Conv. ee (%)Catalyst
1
2
3
4
5
6
7
8
I
II
III
IV
V
VI
VII
VIII
99 92 99 87 99 92
99 79 99 65 99 65
99 81 99 62 99 78
99 67 99 81 99 88
99 65 99 43 99 59
99 35 99 17 99 26
99 93 99 86 99 84
59d 94 99 94 99 92
16
Table2.2Asymmetrichydrogenationofminimallyfunctionalizedcyclohexadienes.a
aReactionconditions:0.125mmolofsubstrate,0.5mol%catalyst,1mLofCH2Cl2,50barofH2,17h,r.t.
bPredictedabsolutestereochemistryforthemajorproduct(>90%transselectivity observedwhere applicable, unless otherwise stated). cIsolated yield unless
99e 99
Entry Substrate Productb Catalyst Yield (%)c ee (%)d
R3
R2R1
R3
R2R10.5 mol% catalyst
50 bar H2, CH2Cl217 h, r.t.
14a-34a 14b-34b
R1 R2 R1 R2
14a: R1= Me, R2 = Me 14b1
15a: R1= Et, R2 = Et 99e,f 9415b2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
16a: R1= i-Pr, R2 = Et
17a: R1= i-Pr, R2 = i-Pr
18a: R1= Me, R2 = Ph
19a: R1= Me, R2 = Ph-4-Me
20a: R1= Me, R2 = Ph-4-CF3
21a: R1= OMe, R2 = Me
22a: R1= OMe, R2 = i-Pr
23a: R1= i-PrO, R2 = Me
24a: R1= OMe, R2 = i-Bu
16b
17b
18b
19b
20b
21b
22b
23b
24b
99e,f
76e
91
81
99e
99e,f
99e
71e
96
99
99
99
99
99
99
98
9968
PentylMeO PentylMeO81 98I26a 26b
25a: R1= OMe, R2 = OMe 25b VII 99e 99
OMeMe
Me
R1 R2
R3
OMeMe
Me
R1 R2
R3
99e 99
99e 94
99e 98
99e 92
99e 98
31b31a
27a: R1, R2 , R3 = Me 27b
28a: R1= Me, R2, R3 = Et
29a: R1= Me, R2 = OMe R3 = i-Pr
30a: R1= i-Pr, R2 = OMe R3 = Me
28b
29b
30b VII
VII
VII
VII
MeO OMe
OMe
MeO
MeO OMe
OMe
MeO82 98
98 99
72 99
32a 32b
33b33a
34a 34b
I
VII
VII
I
VII
VII
VII
VII
VII
VII
VII
VII
VII
VII
VII
17
otherwise specified. dDetermined by HPLC or GC analyses using a chiral stationaryphase.eConversiondeterminedby1HNMRspectroscopy.fSelectivitytotrans<90%.
Employing substrates containingphenyl,p-tol andp-CF3-tol didnot affect thereaction and catalyst VII was still the best catalyst resulting in excellentenantioselectivity (99% ee, entries 5-7). The acid labile methyl ether groupswere also well tolerated by this catalytic system, once again catalyst VIIperformedwellandprovidedee’sup to99%(entries,8-12and16-17). In fewinstances,thecatalystcontainingathiazole(cat.I)motifprovedtobeeffective(entries13,18and20).Forbicyclicsubstrates32aand34aonceagaincatalystVIIperformedwell, furnishinghighenantioselectivityupto99%ee (entries19and21).
Table2.3Asymmetrichydrogenationofremotelyfunctionalizedcyclohexadienes.a
aReactionconditions:0.125mmolofsubstrate,0.5mol%catalyst,1mLofCH2Cl2,50barof H2, 17 h, r.t.
bPredicted absolute stereochemistry for the major product (>90%selectivity trans observed where applicable, unless otherwise stated). cIsolated yieldunless otherwise specified. dDetermined by HPLC or GC analyses using a chiralstationaryphase.eSelectivitytotrans<90%.
MeOH
MeOTBDMS
Me
O
OMe
Entry Substrate
1
2
3
Productb Catalyst Yield (%)c ee (%)d
86e 99
84 99
87e 99
MeOH
MeOTBDMS
Me OTBDMS Me OTBDMS
4 97e 92
Me
O
OMe
MeO
OMe
O Me MeO
OMe
O Me
79e 975
35a 35b
36a 36b
37a 37b
38a 38b
39a 39b
R2R1 * R2*R10.5 mol% catalyst
50 bar H2, CH2Cl217 h, r.t.
VII
VII
VII
VII
IX
35a-39a (trans) 35b-39b
18
Cyclohexadienes having functional tethers groups such as OH, OTBDMS, andCOOMeconnectedbyone,twoorthreecarbonsawayfromtheringwerealsoevaluated (Table2.3).Substrateswith the functionalgroup (OH,OTBDMSandphenyl ether) two or three carbons away from the ring were effectivelyhydrogenated with catalyst VII affording enantioselectivity up to 99% ee(entries1-3and5).Whenthefunctionalgroup(COOMe)wasonecarbonawayfromthering,catalystIXperformedwell(92%ee,entry4).
Table2.4Asymmetrichydrogenationofcyclicolefinswithring-bondedfunctionality.a
aReactionconditions:0.125mmolofsubstrate,0.5mol%catalyst,1mLofCH2Cl2,50barofH2,17h,r.t.
bPredictedabsolutestereochemistryforthemajorproduct(>90%transobservedwhere applicable, unless otherwise stated). cIsolated yield unless otherwisespecified. dDeterminedbyHPLCorGCanalysesusinga chiral stationaryphase. e>95%trans-dimethyl product. fFor both cis-fused diastereomers (1:1). gConversiondeterminedby1HNMRspectroscopy.
Substrates bearing functional groups attached directly to the cyclohexadienering (class 2) were also evaluated (Table 2.4). Having acid moieties directly
Entry Substrate
1
4
3
Productb Catalyst Yield (%)c ee (%)d
99g 97
91e 99
98f 99
2 98e 99
COOMe
COOMe
Me
COOHMeMe
O
Me
COOH
MeMe
COOH
MeMe
COOMe
COOMe
Me
O
Me
COOHMeMe
O
Me
O
Me
40a 40b
41a 41b
rac-42a
42b
42c
+ +
43a 43b
I
X
VII
VII
R3
R2
R3
R20.5 mol% catalyst
50 bar H2, CH2Cl217 h, r.t.
40a-43a 40b-43b
R1 R1
EWG EWG
19
bondedtotheringresultedinhydrogenationswithexcellentenantioselectivityand high yields, 91% and 98% respectively (entries 1 and 2), but in this casecatalystsIandXturnedouttobethebest.Hexahydronaphthalenone42awasalso hydrogenated to the desired product in high selectivity (99% ee) withcatalystVII.Thepresenceoftwoestergroupsontheringdidnotinfluencethereactivity and selectivity and provided the desired product in 97% ee withcatalystVII(entry4).
Table 2.5 Asymmetric hydrogenation of unsaturated cyclohexadienes connected toheterocycles.a
aReactionconditions:0.125mmolofsubstrate,0.5mol%catalyst,1mLofCH2Cl2,50barofH2,17h,r.t.
bPredictedabsolutestereochemistryforthemajorproduct(>90%trans
NH
MeO
NH
NHMeO
N
OMe
NTs
Me
S
Me
Ts
Entry Substrate
1
2
3
Productb Catalyst Yield (%)c ee (%)d
85 90
98 99
83 92
4 99e 99
99e 995
n-Bu
n-Bu
NH
n-Bu
NH
n-Hex
6
7
8
NH
MeO
NH
NHMeO
N
OMe
NTs
Me
S
Me
Ts
n-Bu
n-Bu
NH
n-Bu
NH
n-Hex
98 90
99e 99
99e 99
44a 44b
45a 45b
46a 46b
47a 47b
48a 48b
49a 49b
50a 50b
51a 51b
VII
VII
VII
VII
I
I
I
II
0.5 mol% catalyst
50 bar H2, CH2Cl217 h, r.t.
44a-51a 44b-51b
R1 R1
NH
NH
20
selectivity observed where applicable). cIsolated yield unless otherwise specified.dDetermined by HPLC or GC analyses using a chiral stationary phase. eConversiondeterminedby1HNMRspectroscopy.
Lastly,carbocyclescontainingheterocyclicmotifs (class3)wereevaluatedandscreenedwiththeN,P-iridiumcatalyticsystem(Table2.5).CatalystVIIworkedwell for the substrates bearing Me and OMe groups, both on indole andcarbazole derivatives (entries 1,4-5 and 7). However, substrates bearing longalkyl chains (n-Hex and n-Bu) were handled better by catalyst I (Table 2.5,entries2and3)giving90%and92%ee respectively,except for thecarbazolewith then-Bugroup (49a), inwhich case catalyst II gavehigh selectivity (90%ee,Table2.5,entry6).Forthethiophenesubstrate(51a)catalyst I resulted inhighenantioselectivity(99%ee,Table2.5,entry8).The asymmetric hydrogenation of the majority of substrates smoothlyconverted them to the desired saturated carbocycles in a clean reaction andhighconversion.
2.2.3 Regioselectivemonohydrogenations
Typically the N,P-iridium catalyzed asymmetric hydrogenation of di- andtrisubstitutedolefinsproceedswithfullconversiontothesaturatedproductinvery high enantioselectivities at 20-50 bar of hydrogen, while the morechallenging tetrasubstituted olefins are left untouched. However, with thenewly developed imidazole catalyst VII, it was possible to discriminate alsobetween two trisubstituted olefins based on their steric and electronicproperties. For instance, cyclic dienes having amethyl group and a aromaticgroup,wheretheolefinπ-electronispartiallydelocalizedintheringgaverisetoconsiderable regioselectivity. Most likely, less steric bulk and higher electrondensity on the olefin facilitate its coordination to the metal, makinghydrogenation faster. The regioselectivity of the monohydrogenation wasoptimized on the two selected substrates 20a and 51a and the results arepresented in Table 2.6. At 50 bar of hydrogen pressure, the olefins werehydrogenatedto the fullysaturatedproducts in17h (Table2.6,entries1and3). However, a decrease in hydrogen pressure or reaction time leads to theselective formation of mono-hydrogenated compounds (Table 2.6, entries 2and 4). The productwas obtained in 83% and 94% conversionwith excellentenantioselectivity(99%ee).
21
Table2.6Regioselectivemonohydrogenations.a
aReaction conditions: 0.125mmolof substrate, 0.5mol% catalystVII, 1mLofCH2Cl2.EnantioselectivitydeterminedbyHPLCorGCanalysesusinga chiral stationaryphase.Conversiondeterminedby1HNMRspectroscopy.
2.3 Conclusion
Anarrayofimidazolephosphineligands,comprisingbothelectrondonatingandelectron withdrawing substituents on the imidazole were synthesized andappliedsuccessfullyintheasymmetrichydrogenationofcyclicprochiralolefins.The dimethyl imidazole catalyst VII was found to give very highenantioselectivitiesinthereactionandresultedinee’supto99%inhighyield.SubstrateswithacidsensitiveenolethermoietieswereleftintactbycatalystVIIanditalsotolerateacid,alcohol,andheterocyclefunctionalities,thusallowingaconsiderable expansion of the substrate scope. For carbocycles giving rise totwostereogeniccenters,thethermodynamicallyunfavorabletrans isomerwaspreferentiallyobtained.Regioselectivemonohydrogenationswerealsopossibletoachievebytuningthehydrogenpressureandreactiontime.
Me Ph-4-CF3
Me R Me RH2 (bar) Time (h)
5 0.5 94 (99% ee) 6
50 5 83 (99% ee) 17
1
2
Me
S
51a
20a
Entry
4
3
50 17 0 99 (99% ee)
50 17 0 99 (99% ee)
Conv.
R2R1 R2R10.5 mol% catalyst VII
H2, CH2Cl2r.t.
R2R1
+
Ratio
> 99
> 99
> 99
> 99
22
3 Ir-CatalyzedAsymmetricandRegioselectiveHydrogenationofCyclicAllylsilanes.GenerationofQuaternaryStereocentersviatheHosomi-SakuraiAllylation(PaperII)
3.1 Introduction
The regioselective asymmetricmono-hydrogenation of a di-olefin provides anopticallyactivemoleculewhile leavingoneolefingroupuntouched,andcouldlater be used for other chemical transformations. To further enhance theeffectiveness of the procedure, it would be interesting to introduce allylicfunctionalities (such as silanes, stannanes and borane) rather than simpleolefins. These allylic moieties provide possibilities to transform and increasemolecular complexity by applying well-known methods, for example theHosomi-Sakurai allylation. The degree of enantioselectivity otained byasymmetric hydrogenation would then enable the use of optically activeintermediates to direct the stereochemical outcome of succeeding steps. Forexample, in this project, the goal was to retain an allylsilane moiety after aselectivemonohydrogenation and then investigate its use in further chemicaltransformation.
3.2 Hosomi-Sakuraireactionusingcyclicallylsilane
Theadditionofanallylsilanetoanelectrophile inpresenceofLewisacidswasfirstreportedbyHosomiandSakuraiin1976.[37]Thereactionprovidescarbon-carbonbond formationwithexcellentdiastereocontrolundermildconditions.Duetoitsabilitytoconferahighdegreeofstereoselectivity,[38]thismethodhasbeen applied as a key step in the total synthesis of many complex naturalproducts,[39]suchas(+)-Tetronomycin[40]andLycopodiumalkaloids.[41]
23
This well-developed methodology provides a versatile approach to obtainstereochemically defined molecules, which in turn are useful in thepharmaceutical and agrochemical-industry. This has attracted enormousinterest in development of chiral molecules by using chiral Lewis[42] andBrønstedacids[43]aswellopticallyactiveallylsilanereagents.[38b,44]
Figure3.1PreviousworkbyOrgan(a)andShea(b)group.
The major focus for Hosomi-Sakurai allylation has been devoted to acyclicallylsilanes,[38b] and only few examples have been reported on cyclicallylsilanes.[45] The Hosomi-Sakurai allylation on cyclic silanes containing astereogenic center was reported by Organ and co-workers in 1997 (Figure3.1a).[45a] The reaction took place smoothly with electrophiles in presence ofTiCl4resultinginhighdiastereoselectivity.Thestereoselectivitywashighandinsomecases,onlyasinglediastereoisomerwasobtained.Likewise,Sheaandco-workersalsoreportedtheformationofasinglediastereoisomerwhenacyclicallylsilanewasusedundersimilarreactionconditions(Figure3.1b).[45b]Howeverinbothcasesthestartingmaterialswereinracemicform,thusonlytherelativestereochemistry of the products could be controlled. We anticipated thatsimilar transformations could be carried out with a stereochemically definedchiralcenter inproximitytotheallylsilanemoiety, inordertoalsocontroltheabsolutestereochemistry,asoutlinedinScheme3.1.
Scheme3.1Hosomi-Sakuraiallylationwithchiralcyclicallylsilanes.
H Ph
Si OO
O
R HR
Ph
CO2H
OHH
R’R’R
OHR’R
OH
+(a)
(b)
Si(CH3)2Ph
HHR
O
*Si
R2* * *
OH
R3R2
Hosomi-Sakuraiallylation
R1 R1
24
3.2.1 MechanismoftheHosomi-Sakuraiallylation
An open transition state (extended)mechanismwas proposed[46] forHosomi-Sakurai allylationwhen allylsilane is employed (Scheme 3.2). The reaction isinitiatedbytheactivationofacarbonylelectrophilebyaLewisacid,followedbythe addition of the nucleophilic allylsilane.[46-47] A unique and characteristicfeature of allylsilanes is their ability to stabilize the carbocation formeduponthe electrophilic attack. This effect is due to the interaction between the σcarbon-siliconbondwiththeunhybridizedp-orbitalofthecarbocationthroughhyperconjugation,[48]anditisknownasbeta-siliconeffectorbetaeffect(Figure3.2). The mode of addition of the allylsilane nucleophiles determines thestereochemistry of the product. Usually, the antiperiplanar orientation ispreferredinordertoavoidstericrepulsionbetweenthetwobulkysubstituentsof the reagents.[46, 47b] Thus, exclusively syn homo-allylic alcohol is producedupon elimination of the silyl group,which is independent of the geometry ofthestartingallylsilane.
Figure3.2AnexampleofLewisacidcatalyzedallylationofaldehydes.
Scheme3.2TheproposedmechanismforallylationcatalyzedbyLewisacid.
SiMe3 PhCHOTiCl4CH2Cl2 Ph
OH+
Si
Ph
O
TiCl4Hyperconjugation
Ph H
OLA
Me
SiMe3
Ph H
OLA
Me
SiMe3
Ph H
OH
MeH Ph
OH
Me
25
3.3 Resultsanddiscussion
Figure3.3Catalystsusedinthisstudy.
3.3.1 Synthesisofchiralcyclicallylsilane
Itisknownthatallylsilanespossesshighthermalstabilityandarenotsensitiveto oxygen and moisture. In addition, they are relatively inert to a range ofsynthetic methodologies including hydrogenation and oxidation.[46] Thus itmakesthemsuitablesubstratesforthisproject.The unsymmetrical prochiral dienes for the regioselective asymmetric mono-hydrogenation were synthesized as shown in the Scheme 3.3. The benzylsilaneswereeasilyobtainedfromthecommerciallyavailablesubstitutedbenzylalcohol. Benzyl alcohols were converted to benzyl chlorides and subsequentsilylation[49] affords the benzyl silanes (54). The benzyl silanes were furthersubjectedtoBirchreductiontogivethefunctionalizedprochiral1,4.dienes.Theolefinswerethenscreenedforasymmetricregioselectivemono-hydrogenationusingiridiumN,P-catalysts.
S
N
P Ir
PhPh
N
N
P Ir
PhPh
N
N
P Ir
PhPh
N
N
P Ir
PhPh
MeO
OMeN
N
P Ir
PhPh
I II
VII VIIIVI
F
BArF BArF BArF
BArFBArF
26
Scheme 3.3 Synthesisof chiral cyclic substratesviaasymmetric regioselectivemono-hydrogenation.
3.3.2 Optimizationoftheasymmetricmono-hydrogenation
Theregio-andenantioselectivemono-hydrogenationswereinitiallyattemptedon differently trisubstituted olefins 55a (Scheme 3.4). From our previousstudies, it was already known that iridium N,P-catalysts containing thiazole Iand imidazole II ligands were themost successful classes of catalyst when itcomestohydrogenationofcyclohexadienes.[50]Theeffectofhydrogenpressureon the regioselective hydrogenationwas also observed, thus catalyst I, and IIwere evaluated for selective mono-hydrogenation at low hydrogen pressure.Bothcatalystsresultedinfullyhydrogenatedproduct(57).Theintroductionofabulkysilyl (55b)groupand theadditionofbasicadditivessuchasPVP,KHPO4andKH2PO4failedtoimprovetheregioselectivity.
Scheme3.4Regio-andenantioselectiveasymmetricmono-hydrogenation.
Tetrasubstitutedolefinsareusuallylesssusceptibletohydrogenationcomparedto trisubstituted olefins. By taking advantage of this substitution effect, 2,4-dimethyl substituted allylsilane (58) was synthesized and evaluated for theiridium N,P-catalyzed asymmetric mono-hydrogenation. The catalysts I and IIwerescreenedagainandresultedinthedesiredproduct59.Ligandsareknownto have great influence on the acidity of iridium catalysts.[51] The catalystcontainingathiazoleringhadbeenreportedtobemoreacidiccomparedtotheimidazole,[51b]andleadtoloweryieldofthedesiredproduct(Table3.1,entries
OH
R2
Cl
R2
SOCl2DMF
CH2Cl2
Li, DTBBTMSCl
THFSi
R2
Si
R2
Si
R2
Li, NH3t-BuOH
THF
Ir cat. H2
R1R1 R1
R1 R1
52 53 54
55 56
SiR3 SiR3
Cat. I/II,5 bar H2,additives
55a R = Me, 55b R = Et
56a 56b
SiR3
57a57b
+
0 100CH2Cl2,16 h, r.t.
27
1 and 2). The effect of basic additives (PVP and KHCO3); were studied andresultedinanimprovementinreactionoutcome,togetherwithasmallincreaseintheenantioselectivity(from65to71%ee,entries2,3and4).Next,theelectronicpropertiesonthephenylringofimidazolecatalystIIwerestudied. Introducing an electron withdrawing fluoride resulted in poorconversionandenantioselectivity(34%ee,Table3.1,entry5).Substitutingthefluoride with two electron donating methyls at 2,4-positions of the phenyl(catalyst VII) resulted in enhanced reactivity and selectivity, providing 92%conversion with 88% ee (Table 3.1, entry 6). Introducing two even moreelectrondonatingmethoxygroups(catalystVIII),grantedimprovementinbothconversion(95%)andenantioselectivity(98%ee,entry7).
Table 3.1 Optimization of the reaction conditions for the asymmetricmonohydrogenationof58.a
aReactionconditions:0.05mmolsubstrate,0.5mol%catalyst,0.5mLofsolvent,10barof H2, 18 h, r.t.
bYield determined by 1H NMR spectroscopy. cEnantiomeric excessdeterminedbyGCanalysisusingchiralHydrodexβ-6TBDMandHydrodexβ-3P.
7 95 98CH2Cl2
Ir cat. (0.5 mol%)H2 (10 bar)
18 h, r.t. *
Entry Cat. solvent Additive Yield (%)b ee (%)c
1 70 80
2 90 65
5 75 34
6 92 88
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
3 99 70CH2Cl2 PVP
4 99 71CH2Cl2 KHCO3
10 99 99α,α,α-trifluorotoluene
58 59
8 Benzene 93 97
9 Toluene 97 97
Si Si
I
II
II
II
VI
VII
VIII
VIII
VIII
VIII
28
Scheme3.5Possibleprotodesilylationpathwaygeneratingundesiredbyproducts.
Most of the catalysts afforded themonohydrogenated product togetherwithvolatile byproduct 61, probably resulting from protodesilylation of the allylsilaneandfurtherhydrogenation(Scheme3.5).Protodesilylationwasfoundtodecrease drastically with the dimethoxy catalyst VIII, most likely due to itsdecreased acidity and it was thus chosen to screen solvent effects. Solventssuchasbenzene,CH2Cl2,andtoluenegavesimilarresults(Table3.1,entries7-9), however, the use of α,α,α-trifluorotoluene resulted in a much cleanerreactionwithfullconversionand99%ee(Table3.1,entry10).Anumberofcyclicallylsilanesbearingdifferentalkylchainsonthe2,4-and2,5-positions of the ring were synthesized and screened under the optimizedreaction conditions. The results from the asymmetricmono-hydrogenation ofthesesubstratesarepresentedinTable3.2.Thesubstratesbearingethylandn-butyl groups at the 4 and 5 positions of allylsilanes resulted in slightly lowerenantioselectivity (92-94% ee, entries 1,2,5 and 6) compared to the methylgroup.However, the efficiencyof the catalystwas stillmaintained, furnishing84-89%of isolatedyield.Havingan isobutylgrouponposition4didnotaffectthe enantioselectivity (99% ee, entry 3). Similarly, substituting themethyl onposition 2 of the allylsilane to ethyl and n-butyl did not alter theenantioselectivity either (entries 7 and 8). The corresponding chiral cyclicallylsilaneswere obtained in 98-99%ee. Overall, catalystVIII resulted in highreactivityandstereoselectivity.
Si Si
Mono-hydrogenation Protodesilylation
Hydrogenation
58 59 60
61
29
Table3.2Substratescopeoftheasymmetricmonohydrogenationofcyclicallylsilanes.a
aReactionconditions:0.05mmolsubstrate,0.5mol%catalyst,0.5mLofsolvent,10barofH2,18h,r.t.
bPredictedabsoluteconfigurationforthemajorproduct.cIsolatedyield.dEnantiomeric excess determined byGC analysis using chiral Hydrodex β-6TBDM andHydrodexβ-3P.
3.3.3 DiastereoselectiveHosomi-Sakuraiallylation
WetheninvestigatedthereactivityandstereoselectivityofthepreparedchiralallylsilanesintheHosomi-Sakuraiallylation.The2,4-dimethylallylsilane59waschosenasthemodelsubstratewhileemployingbenzaldehydeasthestandard
Ir cat. VIII (0.5 mol%)H2 (10 bar)
α,α,α-trifluorotoluene18 h, r.t.
Si
R2
Si
R2
Entry Yield (%)c ee (%)d
1 84 92
2 84 93
3
70 994
Substrate Productb
Si
Et
Si
Et
Si
n-Bu
Si
n-Bu
62 63
64 65
Si Si
68 69
96 99Si
i-Bu
Si
i-Bu66 67
R1 R1
87 935
89 946
7
8
76 77
Si SiEt Et
Si Sin-Bu n-Bu
70 71
70 99
95 98
Si
Et
Si
Et
Si
n-Bu
Si
n-Bu
72 73
74 75
30
electrophile in presence of a Lewis acid. Different types of Lewis acids wereexaminedand itwas found thatTiCl4was thebestcatalyst,offeringacleanerreactionandhigherstereoselectivity.TheresultsofthescreeningoftheLewisacidsaregiveninTable3.3.A similar level of stereoselectivity was found using SnCl4, but the reactionresulted in complexmixturesbeside thedesiredproduct. Interestingly, in thiscaseacompletereversalofstereoselectivitywasobserved.Inpreviousstudies,SnCl4was foundtoundergotransmetallationwiththeallylsilane.[52]Thiscouldresult in a closed six-membered transition state thus generating thedifferentselectivity. Lewis acids such as BF3�Et2O and SiCl4 did not provide the desiredproduct, and gave instead either a complex reaction mixture or theprotodesilylated byproduct respectively. It is also known that fluoride anionsare capable of activating certain allylsilanes towards electrophile addition bycoordinating to silicon.[53] Nevertheless, we did not observe such reactivitywhenTBAFwastestedwithourallylsilanesubstratesandonlystartingmaterialwere recovered. An increased yield of isolated product was observed whenmolecularsieveswereadded(entry6,from34to68%).TiCl4wasthenchosentooptimizethediastereoselectivityinCH2Cl2at-78°C.
Table3.3ScreeningofLewisacidsfortheHosomi-Sakuraiallylation.a
aReactionconditions:0.15mmolsubstrate,1.1eq.Lewisacid,1.1eq.PhCHO,1.5mLofCH2Cl2,1h,-78°C.
bDiastereomericratiodeterminedby1HNMRspectroscopy.cIsolatedyield.
The reaction between the allylsilanes and aldehydes introduces two newstereogeniccentersintheproduct.Ifthereactionwouldnotbestereoselective,
Si
OH
Ph
CH2Cl21 h, - 78 °C
Lewis acid,PhCHO
59 78a
Entry Lewis acid Yield (%)cAdditive
1
2
3
4
5
TiCl4
SnCl4
SiCl4
BF3.Et2O
TBAF
6 3Å MS 68
TiCl4 -
-
-
34
20
-
-
-
dr b
5:1
5:1
1:6
-
-
-
OH
Ph
78b
+
(relative stereochemistry)
31
the reaction could potentially generate up to eight different stereoisomers.Amongtheseeight,fourstereoisomerscanbeeasilyexcludedbymeansoftheenantioselective asymmetric mono-hydrogenation, leaving only the fourstereoisomersasdepictedinFigure3.4.Thiscanbefurthernarroweddowntotwodiastereoisomersdependingontheallylsilanepreferredmodeofattack,inwhich the incoming electrophile is positioned in such way that its largestsubstituent (the phenyl ring) is oriented away from the cyclohexyl ring toreduce steric repulsion. Finally, there are two possible facial attacks, eitherfromthetoporbottomof thering.Theattack fromthetopface leadstothemore stable chair-like and thermodynamically favored transition state TS 1aandTS1b.Thebottomattackgeneratestwistboatlikeandthermodynamicallyunfavored transition stateTS 2a and TS 2b. Thereby, trans adductswouldbeexpectedforsubstratescontainingamethylat4position, (inaccordancewithOrgan's work), on the other hand, cis adducts will be obtained when thesubstituent occupies the 5 position. These results were further confirmed bythex-raycrystalstructureobtainedforcompound78aand85a(Figure3.5).
32
Figure3.4Proposedtransitionstatesfortheformationof78aand85a.
Figure3.5Crystalstructureofcompound78aand85a
HPh
OTiCl4
Si
SiHPh
OTiCl4
SiSi
Above
Below
H Ph
OCl4Ti
SiH Ph
OCl4Ti
SiHPh
OTiCl4
Si SiHPh
OTiCl4
Unfavored
Favored
Si
Si
OH
Ph
TiCl4
OH
Ph
TiCl4
OH
Ph
TiCl4
OH
Ph
TiCl4
Ph
OH
Ph
OH
transMajor
cisMinor
TS 1a
TS 2a
SiHPh
OTiCl4
Above
Ph
OH
cisMajor
TS 1b
12
345
6
123
45
6
123
45
6
4-Substituted
4-Substituted
5-Substituted
Si
OH
Ph
TiCl4
Si
OH
Ph
TiCl4
78a
78b
85a
HPh
OTiCl4
SiSi
Below
Si
OH
Ph
TiCl4
OH
Ph
TiCl4
Ph
OH
transMinor
TS 2b
123
45
6
5-Substituted
85b
654
321
OH
Ph
654
321
OH
Ph
654
321
OH
Ph
654
321
OH
Ph
78a 85a
33
It was found that the ratio of the two observed diastereoisomers could befurther optimized. After numerous experiments, an improvement indiastereoselectivity was observed by increasing the concentration of thereaction (Table 3.4). This lead us to study the concentration effects of theindividual reagents and the allylsilane.When the reactionwas run at 0.3M adecrease in diastereoselectivity was observed with higher concentration ofbenzaldehyde (entry5), on the contrary, increasing the concentrationof TiCl4gave rise to very high diastereoselectivities (entry 6). The reason for thisconcentration effects are still unknown to us and have no literatureprecedence.
Table3.4ConcentrationdependenceintheHosomi-Sakuraiallylation.
aDiastereomericratiodeterminedby1HNMRspectroscopy
A range of carbon electrophiles was evaluated under the optimized reactionconditions.Thereactionbetweenthedimethylallylsilaneandvariousaliphaticaldehydes gave overall excellent diastereoselectivity with moderate to goodisolated yields. The results are shown in Table 3.5. Employingcyclohexanecarboxaldehyderesultedinasinglediastereoisomerin65%isolatedyield (entry1).Goodtoexcellentdiastereoselectivitywasalsoobservedwhenisovaleraldehydeandpropionaldehydewereemployedand thecorrespondingproductswereobtained inhighratiosof24:1and46:1,respectively(entries2and 3). Changing to isobutyraldehyde (entry 4) resulted in a decreasediastereoselectivity affording a 9:1 ratio of the desired homoallylic alcohol. A
Si
OH
PhCH2Cl2
1 h, - 78 °C
TiCl4PhCHO
59 78a
Entry Allylsilane (M) dr a
1
2
3
4
0.10
0.26
0.73
3:1
5:1
12:1
30:1
0.03
OH
Ph
78b
+
(relative stereochemistry)
Benzaldehyde (M) TiCl4 (M)
0.10
0.22
0.60
0.03
0.10
0.26
0.73
0.03
5 0.60 2:10.30 0.30
6 0.30 45:10.30 0.60
34
highdrof49:1wasalsoobservedwhencyclopentanecarboxaldehydewasused(entry5).
Table3.5SubstratescopefortheHosomi-Sakuraiallylation.a
aReaction conditions: 0.30mmol substrate, 1.1 eq. TiCl4, 1.1 eq. aldehyde, 0.5mL ofCH2Cl2, 1 h, -78 °C.
bIsolated yield. The lower yields are most likely due toprotodesilylation and loss of volatile byproducts. cDiastereomeric ratio and relativestereochemistrydeterminedby1HNMRspectroscopy.
*
OH
R3R2
CH2Cl2, 3Å MS1 h, - 78 °C
TiCl4R3CHOSi
R2
Entry Yield (%)b dr c
7
69 single stereoisomerobserved8
37 34:19
6
Product
OH
Ph
Et
OH
Ph
n-Bu
42 31:1
OH
Ph
OH
Phi-Bu 30 24:1
*
OH
R2+
1 65 single stereoisomerobserved
2 32 24:1
3
4
OH
Cy
OH
i-Bu
40 46:1
OH
Et
56 9:1
OH
i-Pr
5 42 49:1
OH
R1R1 R1
R3
79
80
81
82
83
84
85
86
87
a b
35
The scope of the reactionwas further studied by varying the allylsilanes andemploying benzaldehyde as the standard electrophile. Interchanging methylgrouponcarbon4ofthecyclicallylsilanetoanisobutylgroupdidnotaffectthediastereoselectivity(24:1,entry6).Movingthemethylgroupfromcarbon4tothe 5 position did not influence the level of diastereoselectivity either andfurnished thecis alcoholwitha31:1dr (entry7). The reactionon the5-ethylsubstitutedallylsilaneaffordedasinglediastereoisomer(entry8)andswitchingtoan-butylgroupresultedinadrof34:1(entry9).
3.4 Conclusion
In conclusion, a number of differently substituted dienes containing anallylsilane were synthesized and screened for the asymmetric iridium N,P-catalyzed regioselective mono-hydrogenation. The effect of the electronicpropertiesoftheN,P-ligandwasfoundtobesignificantforbothreactivityandstereoselectivity. Thus, excellent ee’s (92-99%) could be obtained employingimidazole-basediridiumcatalystVIIIreachingisolatedyieldsof70–96%forthechiralallylsilanes.High diastereoselectivity was obtained in the subsequent Hosomi-Sakuraireactionforthechiralallylsilanesgivingrisetotwonewstereogeniccentersinarelatively short synthetic route, starting fromachiral reagents.Thisdevelopedmethodologygeneratesstericallycrowdedquaternarystereogeniccentersnextto a homoallylic alcohol; these can in turn could serve as interesting chiralbuildingblockforfurtherchemicaltransformations.
36
4 N,P-IridiumCatalyzedAsymmetricHydrogenationofVinylfluorides
4.1 Introduction
Organofluorine compounds are almost entirely absent in nature;[54] however,theirgrowingapplicationinthelifescienceshasinspiredasubstantialresearchinterest, in particular in development of drug and agrochemicals.[55] Thefluorine atom possesses strong electron withdrawing properties with anelectronegativity value of 4, and as a consequence the C-F bond is highlypolarized.[56]This increasesthestrengthoftheC-Fbondtoapproximately116kcal/mol, representingoneof thestrongestknown inorganicchemistry.[55b,57]The incorporation of fluorine atoms in molecules generally enhances theirthermalandoxidativestability,whichconfersanadvantageouseffectontheirbiological properties.[55b,57b] In thepast fewdecades, thenumberofbioactivemoleculescontainingfluorineatomshaveincreasedtremendously:from2%in1970 to more than 18% in pharmaceuticals and even higher (28%) inagrochemicalsin2006.[55c]Thesefiguresareexpectedtorisegloballytoaround20-25%ofdrugcandidatesdevelopedinthepharmaceuticalindustry.
Figure4.1Fluorinecontainingbioactivemolecules.
N
O
OO
Ezetimibe
N
ON
N
FFOH
(a) (c)
N
O
OH
OH
F
F(b)
Azetidinone
N
ON
N
F
FFOH
(d)
KSP inhibitors
37
Inpharmaceuticals, fluorine isusuallyappliedasachemically inertbioisostereofhydrogentomodulatethephysiochemicalandpharmacokineticpropertiesofdrug molecules (bond strength, lipophilicity, conformation, pKa, tissuedistribution route and rate of metabolism).[55a, 57b, 58] For example, theintroduction of a fluorine atom in azetidinone (a cholesterol absorptioninhibitor, Figure4.1aand4.1b) increases themetabolic stability.[58-59]Anotherexample is the kinesin spindleprotein (KSP) inhibitor (Figure4.1c),where thefluorinated analogue (Figure 4.1d) has shown to reduce the basicity of theamine.[60]There are various asymmetric methodologies developed to generate fluorinecontaining stereogenic centers for example electrophilic fluorination ofaldehydes using organocatalysts,[61] fluorination using chiral metalcomplexes,[62] and NHC-catalyzed fluorination of aliphatic aldehydes (Figure4.2).[63]However,thecatalyticasymmetrichydrogenationoffluorinecontainingolefins has been reported only a few times. In 2002 Saburi and co-workersreported the asymmetric hydrogenation of (E)- and (Z)-2-fluoroalkenoic acidsusing a Ru-BINAP catalyst.[64] High enantioselectivity (up to 91% ee) wasobtainedwith1mol%ofcatalyst,at5barH2 in24h.Thepreferredchoiceofsolventismethanolandthereactionwascarriedoutat50°C(Figure4.3a).
Figure4.2Examplesofasymmetricfluorination.
R
CHOOH
R
N N
NOR
OR
F
NFSINHC
NFSI
RH
O ROH
F
N
NH
O
Ph
·DCA
(20 mol%)
2. NaBH4, CH2Cl2/EtOH, r.t.
1
RO
ClR
O
Nu
F1. BQd,
trans-(PPh3)2PdCl2NFSI, Base
2. NuH
N
OMe
NOCOPh
BQd
(a) Fluorination via organocatalysis
(b) NHC catalyzed fluorination
(c) Transition metal catalyzed fluorination
NFSI, THF/IPA - 20 ºC
38
Figure4.3Examplesofasymmetrichydrogenationofvinylfluorides.
Using a similar reaction condition Nelson and co-worker also reported theasymmetric hydrogenation of vinyl fluorides employing Walphos ligand and[Rh(COD)Cl]2/[(norbornadiene)2Rh]BF4asthecatalystprecursor(Figure4.3b).[65]An excellent enantioselectivity (up to 98% ee) was obtained with 99%conversion.In this chapter, the generation of enantiomerically enriched C-F compoundsthroughN,P-iridiumcatalyzedasymmetrichydrogenationofvinylfluorideswillbediscussed.VariousN,P-iridiumcomplexeswerepreviouslydevelopedintheAnderssongroupfortheasymmetrichydrogenationofvinylfluorides,butwerestudied only on α-fluorocinnamyl derivatives. Therefore, wewanted to studyandwidenthescopeofthereaction.
4.2 Substratesynthesis
Tri- and tetrasubstituted vinyl fluoride substrates can be easily prepared asshown in Scheme 4.1. A range of α, β-unsaturated esters containing an α-fluorineatomwasreadilysynthesizedbyapplyingthewellestablishedHorner-Wadsworth-Emmons method A. The reaction of triethyl 2-fluoro-2-phosphonoacetate 88 with aldehydes 89 (A1),[66] ketone 92 (A2),[67] andglyoxylate95 (A3)[68]gavemixturesofEandZα-fluoro-α,β-unsaturatedesters(90,93and96).TheestersweresubsequentlysubjectedtoDIBALreductiontogivethecorrespondingalcoholproducts91and 94.TheEandZ isomersweresimplyseparatedbyflashchromatographyeitherattheesteroralcoholstage,dependingontheirpolarityandhowwelltheycouldbeseparatedoncolumn.In few cases, where it was too difficult to separate them, the stereospecificMizoroki-Heckreaction[69](Scheme4.2)wasemployed.
RF
COOHR
F
COOH
PPh2PPh2
5-50 bar H2Ru-(R)-BINAP
MeOH, 50 ºC,24 h
NBn
up to 91% ee
(a)
F
OH
H
Cl(b) N
Bn F
OH
6 bar H20.1 mol% [(COD)RhCl]2
(R)-(R)-WalphosMeOH, 50 ºC,
15-16 h98% ee
(R)-BINAP
Fe
P(c-C6H11)2
PPh2
(R)-(R)-Walphos
39
Scheme4.1SynthesisofE/Zvinylfluorides.
Scheme4.2Stereospecificsynthesisofvinylfluorides.
4.3 Resultsanddiscussion
Figure4.4Catalystsusedforthisstudy.
Afterathoroughcatalystscreeningwith0.5mol%catalystat10barH2inCH2Cl2itwasfoundoutthatthebicyclicN,P-iridiumcatalystswithathiazole(XI)andan oxazoline (XII) motifs were the best for vinyl fluorides. With these twocatalysts,anarrayofsubstrateswasscreened.CatalystXIgavethebestresultin the asymmetric hydrogenation of trisubstituted vinyl fluorides (Table 4.1).ThesubstrateZ-100wasfullyhydrogenatedtothesaturatedproduct(101a)inexcellent enantioselectivity (97% ee, Table 4.1, entry 1). A decrease in
PO
O
O
F
EtOEtO
MgBr, Et3N
THF,50 ºC, 1 h
R1 O
O
F
n-BuLiR1 R2
O
- 78 ºC - r.t.R1 O
O
F
R2
88
92
95
R1 H
O 89
E/Z-90
E/Z-93
R1
OO
O
NaHTHF,
0 ºC-r.t., o.n.R1
O O
O
O
F
E/Z-96
A2
A3
R1 OHF
DIBALTHF
- 78 ºC - r.t.
E/Z-94
A1
E/Z-91
DIBALTHF
- 78 ºC - r.t.R1 OH
F
R2
FO
O I Pd(TFA)2, Ag2CO3
Dioxane90 ºC, 4 h
O
O
F+
98 Z-9997
N
S
N
P Iro-Tol
o-Tol BArF
N
O
N
P Iro-Tol
o-Tol BArF
S-XI R-XII
40
enantioselectivityaswellasreactivitywasobservedfortheestersubstrateZ-99(31% conv., 65% ee, entry 2). A similar result was reported previously forcatalystXIIwhentheethylesterversionofZ-99wasemployed(99%conv.,29%ee).[70] Both catalysts gave lower enantioselectivity for olefin E-100with ee’s65%and28%respectively;however,thehighcatalystactivitywasstillretained,giving 99% conversion (Table 4.1, entry 3). For the aliphatic olefin Z-103,catalystXIprevailedonceagainwith84%eecomparedtocatalystXII(76%ee)(entry4).Surprisingly,whenE-aliphaticolefinsE-103andE-105wereemployed,the enantioselectivity was not affected, affording respectively ee’s 86% and92%withcatalystXI(Table4.1,entries5and6).However,withcatalystXIIthehydrogenatedproductwasobtainedinracemicform.
Table4.1Asymmetrichydrogenationoftrisubstitutesvinylfluorides.a
Entry Substrate Conv. (%) (a:b)b ee (%)c
R1
R2R1
F
R2
Catalyst XI, 10 bar H2
CH2Cl2, 24 h, r.t.
1
2
3
4
5
FOMe
O
FOH
F
OH
OHF
F
OH
FOH
6
F R1
R2+
65(-)
97(-)
65(+)
84(-)
86(+)
92(+)
101>99 (99:1)
101>99 (99:1)
104>99(100:0)
104>99 (100:0)
106>99 (100:0)
10231 (99:1)
Z-100
Z-99
E-100
Z-103
E-103
E-105
Catalyst XI Catalyst XII
Conv. (%) (a:b)b ee (%)c
-
80d
28d
76
rac
rac
10199 (94:6)
10199 (97:3)
10483 (100:0)
104>99(100:0)
106>99(100:0)
-
a b
41
aReactionconditions:0.13mmolofsubstrate,0.5mol%catalyst,0.5mlofCH2Cl2,10barofH2,24h,r.t.
bConversionandratiodeterminedby1HNMR.cDeterminedbyHPLCorGCanalysesusingachiralstationaryphase.dDatausedfrompreviousstudy.[70]
Themajorityoftheasymmetrichydrogenationsoftrisubstitutedvinylfluoridesproceeded incleanconversion to thesaturateddesiredproductsat10barH2pressurewith0.5mol%catalystloading.Infewinstances,hydrogenolysisoftheC-F bondwas detected as a side reaction (Figure 4.5).Despite the strongC-Fbond, this hydrogenolytic cleavage of the C-F bond is a common problem inhydrogenationandhaveearlierbeenreportedbothbyus[70]andHudlický.[71] Itwas suggested that the C-F bond breakage occurs either through theenergetically favored five-membered transition state (Figure 4.5a)[72] or via afree radical mechanism (Figure 4.5b), generating carbene or carbene-likespecies in the process. During the transition from sp2 to sp3 carbon, the C-Fbond length is increased approximately by 3% and as a result this leads to adecrease in bond dissociation energy, thus making the C-F bond moresusceptibleforcleavage.
Figure4.5HydrogenolysisofC-Fbondincatalytichydrogenation.
Whencompared todi- and trisubstitutedalkenes, tetrasubstitutedolefinsareusually considered the least reactive class of olefins,mainly due to the stericbulkthathindersthe insertion intothemetalhydrideofthecatalystandthusmakes itmoredifficult to hydrogenate. Additional difficulties also involve thedifferentiation of the prochiral faces of the fully substituted olefin by thecatalyst.Thisdifferentiationbecomesevenmoredifficultwhenthesubstituentsare unfunctionalized.[73] As a result, there are only few reports on theasymmetric hydrogenation of tetrasubstituted olefins having either
HF
OORRO
O
H H
Cat.
HF
OORRO
O
H
Cat.
H H
OORRO
O
H H
Cat.
H- HF H
OORRO
O
H
Cat.
HH
HF
OORRO
O
H H
Cat.
(a)
(b)
42
functionalized(Figure4.6a)[74]orunfunctionalizedsubstituents (Figure4.6b)[75]The challenging and compelling aspect of asymmetric hydrogenation oftetrasubstituted olefins is the ability to generate two contiguous stereogeniccenters in one step. Thus, we wanted to evaluate the N,P-iridium catalystdeveloped in thegroup for theasymmetrichydrogenationof tetrasubstitutedolefins.
Figure4.6Twoexamplesofasymmetrichydrogenationoftetrasubstitutedolefins.
Next,anumberoftetrasubstitutedvinylfluorideswerescreenedusingcatalystsXI and XII. The initial screening using catalyst XI resulted in either lowconversion(3%-8%at100barH2)ornoreactionatall.Increasingthecatalystloading (2 mol%) did not improve the conversion. However, catalyst XII wasfound to hydrogenate tetrasubstituted vinyl fluorides in good conversion andexcellentenantioselectivity.Inthiscaseaswell,aslightlyhighercatalystloading(1.5 mol%) and high H2 pressure (100 bar) was required to obtain highconversion.TheresultsforthesubstratescreeningusingcatalystXIIisshowninTable 4.2. The olefin E-107 was hydrogenated in excellent enantioselectivity(97% ee) with 79% conversion (Table 4.2, entry 1). Introducing a methylsubstituentontheparapositionofthephenylring(E-109)resultedinincreasedconversion(91%)withsamelevelofenantioselectivity(97%ee,Table4.2,entry2).InhydrogenationofthecorrespondingalcoholsE-111andE-113,thedesiredsaturatedalcoholswereobtained in full conversionand theenantioselectivitywasnotaffected,resultingin97%ee(Table4.2,entries3and4).Gratifyinglyinall cases, defluorinated byproducts that are normally amajor concern in thistypeofhydrogenationswerenotobserved.
R1
R2
R1
R2
[Ir(L)COD]BArF
H2
R1 = n-Bu, Ph, EtR2 = Ph
Pfaltz and co-workers (2007)
N
O
Ph
Cy2P
L =
OAc
NHAcO
O OAc
NHAcO
O[Rh(COD)2]BF4, L
H2R1 R1
R1 = Cl, F, OMe, i-Bu
Zhang and co-workers (2017)
(a)
(b)
L = P P
H
H
up to 99% ee
up to 96% eeH
H
43
Table4.2Asymmetrichydrogenationoftetrasubstitutedvinylfluorides.a
aReactionconditions:0.13mmolof substrate,1.5mol%catalyst,0.5mlofCH2Cl2,100barofH2,24h,r.t.
bConversionandratiodeterminedby1HNMR.cDeterminedbyHPLCorGCanalysesusingachiralstationaryphase.dBenzenewasusedinsteadofCH2Cl2.
Replacing either the phenyl or methyl substituent at the β carbon with anadditional ethyl ester resulted in maleic esters E-115 and E-117. Thehydrogenation of E-115 resulted in decreased conversion (47%), but theenantioselectivitywasstillretained,obtainingin99%ee(Table4.2,entry5).Afurther decrease in conversion (32%) was observed with E-117. Neverthelessthe high enantioselectivity was not perturbed, affording 86% ee (Table 4.2,entry 6). However, for both substrates 8-15% defluorinated byproduct wasobserved.
F
OEtO
F
OH
F
OH
F
OEtO
F
O
OEt
OEtO
F
O
OEt
OEtO
Entry Substrate Product Conv. (%) (a:b)b ee (%)c
R1
R3R1
* * F
R3
Catalyst XII, 100 bar H2
CH2Cl2, 24 h, r.t.
1
2
3
4
5
6
FR1
*
R3
+
97(+)
97(+)
97(+)
97(+)
99d(-)
86d(+)
91 (100:0)
Full (100:0)
Full (100:0)
47 (92:8)
32 (85:15)
79 (100:0)
R2 R2 R2
* * F
OEtO
* * F
OH
* * F
OH
* * F
OEtO
* *
F
O
OEt
OEtO
* *
F
O
OEt
OEtO
E-107
E-109
E-111
E-113
E-115
E-117
a b
108
110
112
114
116
118
44
4.4 Determinationofabsoluteconfiguration
Figure4.7DeterminationofabsoluteconfigurationofolefinsZ-100,andE-100.
The enantioselectivity of the reaction depends on the steric interactionsbetween the substrate olefin and coordination sphere around the catalystXIandisbasedonthecomputationalmodelproposedbytheAnderssongroup.[29]Theolefincoordinateverticallytranstophosphorous,andfromtheperspectiveof the olefin the area around the iridium metal can be divided into fourquadrants as shown in Figure 4.7b and 4.7c. The phenyl ring on the thiazoleoccupiesthequadrantiii,whichbecomesstericallyhindered.Theo-tolylgroupson the phosphine partially occupy quadrant ii, which therefore is semi-hindered.Theothertwoquadrants(iandiv)arerelativelyopen.Placingolefintranstophosphorousinsuchwaythatthesmallestsubstituent(H)occupiesthehindered quadrant iii, give the most sterically favored arrangement. As thesubstrate contain two groups (H and F) that are relatively similar in size, onecould imaging that both of these could be accommodated in the stericallyhinderedquadrantandthus leadto lower levelofenantioselectivity incertaincases.For theolefinsZ-100bothorientationsof thedoublebond (positioningeitherHorFinthehinderedquadrantiii(Figure4.7dand4.7e),wouldleadto
Sterically favoredSterically favored?(d) (e)
(S)
FOH
(S)
OHF
i ii
iii iv
i ii
iii iv
OHF
HOH
F
H
Ir
P
N H
H
F
PhH
OH
i ii
iii iv
Semi-Hindered
Hindered Open
Open
i ii
iii iv
(a)
NS
NP
S-XI
(b) (c)
Schematic 3Dquadrant model
Z-100
S-101 S-101
i ii
iii iv
i ii
iii iv
(f) (g)
F
H
OH
F
H
OH
(R)F
OH
(S)
FOH
S-101 R-101
Sterically favored? Sterically favored
E-100
45
thesameenantiomer.However,thestereoisomericolefinE-100wouldleadtooppositeenantiomerdependingonwhetherHor F isoccupying thehinderedquadrantiii(Figure4.7fand4.7g).ThismightbethereasonforthelowerlevelofenantioselectivityobservedforE-100(65%ee)ascomparedtoZ-100 (97%ee).The absolute configuration of the hydrogenated product of Z-100 could beassignedasS-101,andtheonescomingfromZ-105andE-105wereassignedasS-106 and R-106 respectively, based on comparison of the measured opticalrotation with the data reported in the literature (Table 4.3).[70, 76] Theseabsoluteconfigurationsareconsistentwith theprediction fromtheselectivitymodel.Fromtheseresults itcanbeconcludedthatH ismore likely tooccupythemosthinderedquadrantiiiandnotF.
Table4.3Assignedabsoluteconfiguration.a
aAbsoluteconfigurationbasedonselectivitymodelwithcatalystXI.
Entry SubstratePredictedproduct
Absconf. [⍺]
Reported Abs. conf. [⍺]
OHF
OHF
F
OH
(S)
OHF
(S)OH
F
(R)OH
F
Z-100
Z-105
E-105
1
2
3
(S) [ -12.75] (R) [ +12.00]
(S) [ -20.33] (R) [ +28.20]
(R) [ +21.00] -
101
106
106
46
4.5 Conclusion
Tri-and tetrasubstituted olefins containing vinylic fluorine atoms have beensynthesizedandevaluatedforasymmetrichydrogenation.Thebicyclicthiazolecatalyst XI was found to be the best for trisubstituted vinyl fluorides givingenantioselectivities up to 97% ee and >99% conversion. For tetrasubstitutedvinyl fluorides, the bicyclic oxazoline catalyst XII gave excellentenantioselectivity (up to 99% ee) with good to high conversion. It was alsoobservedthathighH2pressure(100bar)wasrequiredforthetetrasubstitutedvinyl fluorides,while trisubstitute vinyl fluorideswere easily hydrogenated atlowH2pressure (10bar).Forboth tri-and tetrasubstitutedvinyl fluorides thereactionproceed smoothly and resulted in desiredproduct in high yields andselectivities. In a few cases a small amount of defluorinated byproduct wasobserved.
47
5 Palladium-CatalyzedCycloisomerizationof1,6-Enynes(PaperIII)
5.1 Introduction
Cycloisomerization is a reaction inwhich a polyunsaturated organicmoleculegetstransformedintoacyclicorpolycycliccompound.Intheprocess,newC-Cbondsare formedwithout lossorgainofanyatomswhileconsumingat leastone degree of unsaturation.[77] Such transformation enables the synthesis ofhighlyfunctionalizedfiveorsix-memberedcarbo-andheterocycliccompoundsfromreadilyavailablestartingmaterials.Considerablyfocushasbeendivertedto the transition metal catalyzed cycloisomerization of polyunsaturatedcompounds to form C-C bonds rather than to its counterpart, the Alder-enereaction, which usually requires harsh conditions.[78] The use of transitionmetals in catalyticamountallows the reaction tobecarriedoutundermilderconditions and also tolerate a range of functional groups, thus extending thepossibilityforfurtherchemicaltransformations.Furthermore,interesthasbeenfocused to theuseof transitionmetal complexes inwhich the ligands canbefine-tuned to achieve optimal reactivity as well as enantio-, regio- and/orstereoselectivity.
5.1.1 Palladiumcatalyzedcycloisomerization
PioneeringworkoncatalyticcycloisomerizationswasreportedbyTrostin1985whileworkingonpalladiummetalcatalyzedalkylations.[79]Itwasreportedthat(Ph3P)2Pd(OAc)2 efficiently catalyze the cyclization of 1,6 enynes via anisomerization under mild reaction conditions. This method was successivelyapplied further by the same group for asymmetric induction using (S)-binaphthoicacid(Figure5.1a)asthechiralligandinpresenceofPd2(dba)3CHCl3and triphenylphosphine (Scheme 5.1).[80] The rearrangement of a 1,6-enyneinto the corresponding Alder-ene type product took place in moderateenantiomericexcess(33%ee).Severalyearslatertheyalsoreportedtheuseof
48
bidentate phosphine ligands (Figure 5.1b),[81] in asymmetric cyclizations,providing50%ee.
Scheme5.1Firstexamplesofcycloisomerizationcatalyzedbypalladium.
Figure5.1Examplesofchiralligandsusedinpalladium-catalyzedasymmetriccyclizationofenynes.
Due to the modest success in asymmetric induction, the enantioselectivecycloisomerizations have been further investigated by fine-tuning the ligandstructureandthechoiceofmetalinordertoachievehigherenantioselectivity.In1996,Itoandco-workersreportedthefirsthighlyenantioselectiveene-typecarbocyclization reaction using a diarylphosphino ferrocene ligand in thepresence of Pd2(dba)3.[82] Similarly, the groupofMikami employed a rangeofBINAP derivatives, providing high enantioselectivity (up to 99% ee).[83] Thiscatalytic system was later applied successfully to the total synthesis ofPhomactinA(Scheme5.2).[84]TheyhavealsoexaminedaN,P-ligandbearinganoxazoline unit (Figure 5.1d),[85] which was equally efficient as its predecessorBINAP ligands: the cycloisomerized product was obtained in highenantioselectivity (up to 99% ee) and good to excellent yield. The chiral
MeO2C
MeO2CPd2(dba)3·CHCl3
PPh3, (S)-binaphthoic acid
MeO2C
MeO2C
61% yield 33% ee
OH
O
OHOH
HNNH
OO
PPh2
Ph2P
a b
P
P
Ar
Ar
Ar
Ar
Fe Fe
c
PAr2PAr2
O
O
O
O
N
O
R2R1
PPh2
R1 = t-Bu, R2 = HR1,R2 = HR1,R2 = Me
Ar = (3,5-Me2-C6H3)
Ar = p-F3C-C6H5
O N N OR
RR
R
R = HR = i-Pr
d e f
49
bidentatephosphineligand(Figure5.1e)hasalsobeenemployedsuccessfullyinene-typecyclizationof1,7-enynes.[85b,85c]
Scheme5.2Theapplicationofasymmetriccycloisomerisationintotalsynthesis.
Recently, several N,P-ligands comprising cyclic and bicyclic frameworks havebeen developed in the Andersson group. The N,P-ligands were successfullyapplied in the iridium-catalyzed asymmetric hydrogenation of functionalizedand unfunctionalized olefins, providing good to excellent enantioselectivity.Thus,weenvisionedthepossibilitytotesttheseligandsincycloisomerizations,which would add a new set to already existing catalyst reported in theliterature.
5.1.2 Mechanismofpalladiumcatalyzedcycloisomerization
Figure5.2Mechanisticpathways.[86]
The mechanism of the transition metal catalyzed cycloisomerization of 1,6-enynescanbecategorizedinthreedistinctcatalyticpathwaysA,BorC(Figure
O
CO2Me Pd(OCOCF3)2(R)-BINAP
O
CO2Me
O
I Ot-BDMS
O
O OHOH
Phomactin A
X
X M
X
X
M
M
X
A
B
C
Metallacycle
π-Allyl complex
Hydrometallation
H
50
5.2) depending on the reaction conditions and the choice of the precatalystused.SinceinthisstudyPdIImetalprecursorswereusedinpresenceN,P-ligandandahydridesource;thereactionpathwayCismostlikelytooccur(Figure5.3).Thus,it will be discussed in further detail. In 1998 Trost proposed this reactionmechanism, suggesting that the Pd0 metal precatalyst in combination with aprotonsourcefavorsaPd0-PdIIcatalyticcycle(PathC),whileaPdIIprecatalystinthe absence of a reducing agentwould promote a PdII-PdIV catalytic pathway(PathA).[87]However, PdII precatalysts inpresenceof P,P-ligands alongwith ahydridesourcearealsoknowntotakepartinaPd0-PdIIcatalyticcycle.In2001Mikami proposed a Pd0-PdII catalytic cycle when Pd(OCOCF3)2 orPd(CH3CN)4(BF4)2precatalystsareusedtogetherwith(R)-SegPhos ligandinthepresence of D2O as the proton source.[83a] From deuterium experiments theyruledoutthatthePdIIhydridespecieswouldbetheactivecatalyst.InsteadtheysuggestedthatthePdIIgetsreducedtoPd0inpresenceoftheligandandoxidizeback to PdII hydride by a hydrogen source. Nevertheless, one cannot entirelyrule out the PdII-PdIV catalytic cycle since both paths will form identicalproducts.
Figure5.3Proposedcatalyticcycleforthepalladium-catalyzedcycloisomerization.
The reaction between the palladium precusor and a hydride donor (HCOOH)first generatesapalladiumhydride species (119),whichuponcoordination tothe alkyne and subsequent hydrometallation gives a vinyl palladiumintermediatethatisconcurrentlycoordinatedtothealkene(122).Thefollowing
[(MeCN)4Pd](BF4)2
PdN
PH
HCOOHN,P-ligand
O
R2R1
R3
O
R1 R2
PdNP
R3
O
R2H R3
PdNP
O
R2 R3
O
R1
PdNP
R2R3
H
120
121
122
123
124
119
51
stepcomprisestheinsertionofthealkeneinthevinylpalladiumtoprovide123,andβ-hydrideeliminationtofurnishtheene-typecyclizedproduct124.
5.2 Resultsanddiscussion
The synthesis of substrates[88] and ligands[89] were carried out as previouslyreported in the literature. The screening of N,P-ligands for the asymmetriccycloisomerizationof1,6-enynesissummarizedinTable5.1.Theallylpropargylether125wasusedasstandardsubstratefortheasymmetric isomerization inpresence of Pd(CH3CN)4(BF4)2 and a chiral N,P-ligand. The reaction proceedssmoothlyat80°CinDMSOin18hourstogivetheene-typecyclicproduct126.It was observed that both the reactivity and the selectivity of the reactiondepend on the ligand structure, as shown in Table 5.1. Imidazole ligandR-L1gave good enantioselectivity (88% ee) but low reactivity and the desiredproductwas isolatedonly in27%yield.Switchingtoa ligandhavingathiazolemoietyR-L2gaveslightlyhigherenantioselectivity(92%ee).
Table5.1EvalutionofthechiralN,P-ligands.a
aReaction conditions: Substrate 125 (0.25 mmol), [(CH3CN)4Pd](BF4)2 (5 mol%), N, P-ligand(10mol%),HCOOH(0.25mmol)andDMSO(2ml),80°C,18h.
However, the yield was low allowing only 23% isolated yield of the product.LigandS-L3 providedan increase in yield, but adecrease in enantioselectivitywas observed (62% ee). Surprisingly, by replacing the phenyl group on the
O
CO2Me
O
CO2Me
[(MeCN)4Pd](BF4)2 (5 mol%)N,P-ligand (10 mol%)HCOOH (1.0 equiv.)
DMSO 18 h, 80 ºC
N
NPh
PPh2
R-L1
27% yield, 88% ee (S)
S
NPh
PPh2
R-L223% yield, 92% ee (S)
NPPh2
S
NPh
S-L352% yield, 62% ee (R)
S
NPh
P(o-Tol)2
S-L468% yield, 99% ee (R)
S
NPh
P(o-Tol)2
R-L5
77% yield, 90% ee (S)
O
NPh
NP(o-Tol)2
R-L643% yield, 22% ee (S)
NP(o-Tol)2
O
N
R-L7
52% yield, 67% ee (S)
O
N
P(o-Tol)2
R-L833% yield, 72% ee (S)
125 126
52
phosphine in ligand R-L2 with an o-tolyl (S-L4) gave an increase inenantioselectivity as well as reactivity. The desired product was obtained in68% isolated yield and in 99%ee. The open chain thiazole ligandR-L5with ahigherdegreeof flexibilitygrantedslightly improvedyieldbutcauseadrop inselectivity. The bicyclic ligands containing the oxazoline moiety (R-L6 – R-L8)werealsoscreened.Thereactionprovidedlowtomoderateselectivity,andtheyieldwas foundtodependonthesubstitutionontheoxazolinegroup.Finallyligand S-L4 proved to be the best both regarding enantioselectivity andreactivityproviding99%eeand68%isolatedyield
5.2.1 Substratescope
LigandS-L4was then chosen to screen a rangeof differently substituted allylpropargylethers(Table5.2).Replacingthemethylestergrouponsubstrate125totrimethylsilane(127) leadtoadramaticdecrease inenantioselectivity (55%ee). Gratifyingly, the high catalytic activity was maintained and the startingmaterial was converted entirely to the product in 18 h, providing 80% ofisolated yield. No improvement in enantioselectivity and reactivity wasobserved when the trimethylsilane group was changed to an isopropyl ester(129) (Table 5.2, entry 2). The substrate affordedmoderate enantioselectivity(52%ee)and78%isolatedyield.IntroducingethylgroupontheC-2carbonofthe olefin (131) resulted in low enantioselectivity (80% ee) whilemaintainingcomparable reactivity to that of substrates 129. A slight increment inenantioselectivityto81%wasalsoobservedwhentheethylwasreplacedwithbenzyl group on the C-2 position of the olefin (133). The substrates withoutmethyl substituent on the C-1 carbon of the olefin (135) resulted in lowenantioselectivity(31%ee)aswellassubstrateswithamorestericallycrowdeddoublebond(137).Nonetheless,highreactivitywasretainedgivingupto80-84%yield.Thesubstratebearingan isopropylgroup introducedat theC-2positionoftheolefin(E/Z139)didnotisomerizeunderstandardconditions.
53
Table5.2Substratestudyofcycloisomerizationof1,6-enyneswithS-L4.a
aReaction conditions: Substrate (0.25 mmol), [(CH3CN)4Pd](BF4)2 (5 mol%), N,P-ligand(10mol%),HCOOH(0.25mmol)andDMSO(2ml),80°C,18h.bNMRyield.
Raising the reaction temperature and a higher loading of catalyst failed toimprovetheresult.Thepossibleexplanation for thisobservationcouldbethestericbulkinessoftheisopropylgroup,whichisinhibitingthecyclizationorthebeta-hydrideeliminationstepinthecatalyticcycle.
O
R3
R4
O
R3 R4
[(MeCN)4Pd](BF4)2 (5 mol%)S-L4 (10 mol%)
HCOOH (1.0 equiv.)
DMSO 18 h, 80 ºC
R2
R2R1
Entry Substrate Product Yield (%) ee (%)
O
CO2i-Pr
O
CO2i-Pr
O
TMS
O
TMS
O
CO2Me
O
CO2Me
O
CO2Me
O
CO2Me
O
CO2Me
O
CO2Me
O
CO2Me
O
CO2Me
O
CO2Me
O
CO2Me
Ph Ph
1
2
3
4
5
6
7
80 55
78 52
75b 80
75 81
84 31
80b 22
- -E-139Z-139
R1
127
129
131
133
135
137
140
138
136
134
132
130
128
C-2
C-1
54
5.2.2 Investigationofthehydrogensource.
IthasearlierbeensuggestedbyMikamithattheactivecatalyticspeciesconsistof the palladium hydride, which in turn can be readily generated frompalladium precatalysts in the presence of a hydrogen source. A range ofadditives has been screened under standard conditions using ligandR-L5 and[(CH3CN)4Pd](BF4)2 with substrate 135 (Table 5.3). Under standard conditionsligandR-L5gave84%isolatedyieldand31%ee(entry1).Withoutanyadditives,the reaction still proceeded smoothly, providing complete conversion to thecyclic product in 18 h. However, using freshly dried DMSO the reactionproceedsconsiderablyslowercomparedtowetDMSO.Fromthisresult itwasconcluded that the water present in the wet DMSO was sufficient to act ashydrogen source to generate the palladium hydride species, which in turnacceleratesthereactionrate.
Table5.3Investigationofthehydrogensources.a
aReaction conditions: Substrate 135 (0.25 mmol), [(CH3CN)4Pd](BF4)2 (5 mol%), N,P-ligand(10mol%),HCOOH(0.25mmol)andDMSO(2ml),80°C,18h.
Asimilarresultwasobservedwhenwaterwasdirectlyemployedasanadditive.In almost all cases full conversionwereobserved,with 80-84% isolated yield.However, the enantioselectivity was significantly affected giving 31% to 12%and 10% ee respectively (entries 1-3). The effect of the hydride source wasfurther examined using methanol and trifluoroethanol. The high catalyticactivitywasstillmaintained inbothcases,andan increasedenantioselectivitywasobservedwhencomparedtotheadditionofwaterorremovalofadditives
O
CO2Me
O
CO2Me[(MeCN)4Pd](BF4)2 (5 mol%)
(R)-L5 (10 mol%)additiveDMSO
18 h, 80 ºC
Entry Additive Amount (equiv.) Conversion (isolated yield (%)) ee (%)
1 HCOOH 1.0 99 (84) 31
2 - - 99 (80) 12
3 H2O 50 99 (82) 10
4 MeOH 50 99 (82) 25
5 TFE 50 99 (79) 29
135 136
55
(entries4-5);usingtrifluoroethanolresultedinslightlyhigherenantioselectivitycomparedtomethanol.
5.3 Enantioselectivityandabsoluteconfiguration
Figure5.4Selectivitymodelforenantioselectivity.
TheabsoluteconfigurationoftheproductgeneratedwiththeuseofligandR-L2and S-L4 can be predicted from a quadrant selectivity structuremodel. Themodeltakes intoaccountthedegreeofsterichindranceinthefourquadrantsaroundthemetalcenter,accordingtotheligandandthemodeofcoordinationoftheincomingolefin(transtophosphorous).ThephenylsubstituentontheN-heterocyclic and the phosphine occupy two of the four quadrants (i and iv);makingthemrespectivelyhinderedi,andsemi-hinderediv,whiletheothertwoquadrants are left relatively open (ii and iii). In the stereodetermining step(Figure 5.3 122) the olefin is arranged in such a way that the hydrogen, thesmallest substituent, resides in the most hindered quadrant i (Figure 5.4b),whileitsbulkysubstituentremainsintheopenquadrant(iiandiii).AnewC-Cbondisformed,andonestereogeniccenterisgeneratedintheproductduringthecyclizationstep(Figure5.3123).Theabsoluteconfigurationoftheproductcanbederivedfromthequadrantmodelasseen inFigure5.4band5.4e.ThehinderedquadrantiofligandR-L2favorstheformationofS-126andligandS-L4
PS
N
i ii
iii iv
PdN
S
P
i ii
iii iv
Pd
N
S
PPd PS
N Pd
i ii
iii iv
i ii
iii ivR-L2 S-L4
NS
PPd
i ii
iii iv
Sterically favored Sterically unfavored
HO
CO2Me
O
CO2Me
a d
b c e
O
CO2Me
O
CO2MeO
CO2MeS-126 R-126 R-126
H
HO
CO2Me
56
(holdingoppositeconfigurationcomparedtoR-L2generatesmostthehinderedquadrant at iii, resulting in the formation of R-126. All the absoluteconfiguration predicted by this model was found in agreement withexperimentalmeasurementasshowninTable5.1.
5.4 Conclusion
ArangeofN,P-ligandswerestudied in theasymmetricene-typecyclizationof1,6-enynesusingapalladiumprecatalystwithHCOOH.The cycloisomerizationof allyl propargyl ethers took place efficiently by the catalytic system, givingmoderatetogood isolatedyields.Theenantioselectivitywas foundtodependbothon the ligand structure and thehydride source. The ligandS-L4was thebestinordertodeliverhighenantioselectivity(upto99%ee)usingHCOOHashydride source. The reaction provides a challenging quaternary stereogeniccenter inproximityofdifferentfunctionalities,whichinturncanbeappliedtofurtherchemicaltransformation.
57
6 PopulärvetenskapligSammanfattningpåSvenska
Arbetet som presenteras i denna avhandling avser asymmetrisk katalysmedanvändningavkiralaN,P-liganderochiridiumellerpalladiummetaller.Den första delen (kapitel 2 och 3) behandlar N,P-iridiumkatalyseradasymmetrisk hydrogenering av 1,4-cyklohexadiener som harfunktionaliseradeoch/ellerofunktionellasubstituenter,inklusiveallylsilan-sidokedjor. En serie N,P-iridiumkatalysatorer syntetiserades ochutvärderades på ett antal cyklohexadiener. De utvecklade N,P-iridiumkatalysatorerna resulterade i utmärkt kemo-, regio- ochenantioselektivitet för de flesta av de erhållna produkterna. För substratsom har en allylsilan sidokedja användes de bildade kirala cykliskaallylsilanerna för att inducera stereokontroll i en efterföljande Hosomi-Sakurai-reaktionmed användning av TiCl4 som Lewis-syra och aldehydersom elektrofiler. Produkterna, homoallyliska alkoholer, erhölls i god tillutmärktdiastereoselektivitet.Denandradelen(kapitel4)beskriverN,P-iridiumkatalyseradasymmetriskhydrogenering av olika vinylfluorider. Ett antal tri- och tetrasubstitueradevinylfluorider syntetiserades och utvärderades i den asymmetriskahydrogeneringen. Produkterna, mättade kirala fluorföreningar, erhölls imyckethögenantioselektivitet(upptill99%ee).Defluorinering,somärenvanlig sidoreaktion under de katalytiska hydrogeneringsförhållandena,observeradesejförmajoritetenavsubstraten.Slutligenbeskriverkapitel5tillämpningenavN,P-liganderidenasymmetriskacykloisomeriseringenav1,6-enyner med användning av en palladium-katalysator.Enantioselektivitetenförprodukternabefannsberobådepåsubstratetochvätekällan.De utvecklade katalytiska reaktioner som beskrivs i denna avhandlingtillhandahållerattraktivametoderförattskapaflerastereogenacentraienmolekylirelativtfåstegochfrånlättillgängligautgångsmaterial.
58
AppendixA:Contributionlist
I. Enantio-andRegioselectiveIr-CatalyzedHydrogenationofDi-andTrisubstitutedCycloalkenesSynthesized six catalysts and five substrates and took part in thescreeningofthereaction.Participatedinthepreparationofthesupportinginformation.
II. Ir-Catalyzed Asymmetric and Regioselective Hydrogenation ofCyclicAllylsilanesandGenerationofQuaternaryStereocentersviatheHosomi-SakuraiAllylationSynthesizedthemajorpartofthesubstratesandperformed≈80%oftheexperiments.Participatedinthepreparationofthemanuscriptandthesupportinginformation.
III. N,P-IridiumCatalyzedAsymmetricHydrogenationofVinylFluoridesSynthesisofallsubstratesandtookpartinscreening.Participatedinthepreparationofthesupportinginformation.
IV. Thiazole,ImidazoleandOxazolineBasedN,P-LigandsforPalladium-CatalyzedCycloisomerizationof1,6EnynesSynthesizedathirdoftheligandandsomesubstrates.Participatedinthepreparationofthesupportinginformation.
59
Acknowledgements
Iwouldliketoexpressmydeepestappreciationtothoseenthusiasticandhighlydevotedpeoplearoundme:First and foremost, my utmost gratitude to my supervisor, Prof. Pher GAndersson, for accepting me as a Ph.D. candidate in his group. Your help,inspiring suggestions, and encouragement helpedme all the time during theresearch.Youhavesupportedmethroughoutmystay inthedepartmentwithyour patience and knowledge, whilst providing me with an excellentatmospherefordoingresearch.Thankyouforalltheeffortsyouhaveputintomakemeabetterresearcher.Specialthankstomyco-advisorProf.BjörnÅkermarkforhisexcellentguidance,caring, patience and providing a comfortable environment to discuss. Dr.MarkusKärkäsforbeingawonderfulcollaboratoraswellasbeingmyguidanceandthanksforintroducingmetoartificialphotosynthesis.Dr. Janjira Rujirawanich (Nan), for your help and suggesting me to Pher.Dr.Pushpesh Upadhyay, for being wonderful lab colleague and an encouragingperson.Dr.VijaySinghParihar,IreallyappreciateyourhelpwhenIfirstmovedtoSweden.Dr.ThishanaSingh,thankyouforyouradviceandsupport.Dr.ByronPeters, the most knowledgeable chemist in the group whom I admire andrespect a lot. Always ready to give a helpinghand andprovide thenecessarysupport, both in and outside the lab. Thank you for helping me withinstrumentsandIhopeonedaywewillmeetagain.Dr.XuQuan,thehumoristand charismatic twin brother. Thank you for being supportive and I enjoyedyourcompanybothinandoutsideworkinghours.Dr.JianguoLiu,aninnocentbut cheerful colleague, I really enjoyed talking and sharing about our lifeexperiences and I will cherish it forever. Sutthichat Kerdphon, the loudestperson in the lab, I enjoyed your company and will cherish our friendshipforever. Cristiana Margarita, a conscientious and diligent person, I reallyenjoyedworkingtogetherwithyou.Thankyouforproofreadingmythesisandgiving suggestions. Suppachai Krajangsri, the DJ, and vocalist of the group,thanksforbeingniceandverysupportivecolleague.HaiboWu,atalkativeand
60
sociable person, my brother, thank you for your help. Jiangping Yang, thequietest and hard-working person, thanks for your help. Dr. Sudipta Ponra,thanksforbeingsupportiveandIreallyenjoyedworkingtogetherwithyou.Dr.JiaZheng,aniceandsupportivecolleaguethanksforthehelp.I would like to acknowledge the financial, academic and technical support oftheuniversityandtheirstaff.CarinLarsson,KristinaRomare,MartinRoxengren,andOlaAndersson.fortheirtechnical support. Jenny Karlsson, Louise Lehto, Sigrid Mattsson and GülsünKücükgölfortheirsupportinadministrativework.Manythankstomycolleaguesinthedepartment:Dr.AnonBunrit(IenjoyedyourcompanybothinSwedenandThailandandnottomentionaboutyourwonderfulanddeliciousfood),Dr.SunisaAkkarasamiyo,Dr. Rahul Watile, Elena Subbotina, Pemikar Srifa, Phakinee Khunsirikulwanit,Jasmine Ingboon, Dr. Jéssica Margalef, Dr. Supaporn Sawadjoon, AndreyShatskiy,Dr.TanjaLaine,Dr.AhmedF.Abdel-Magied,AlessandroRuda,StalinReddyPathipati,Dr.MarcMontesinos,ViolaHobiger,Dr.GrecoGonzalezMiera(Mybrother,thankyouforyoursupport,adviceandforalwaysbeingtheretohelpme),HaniMobarak,SamuelMartinezErro,DongWang,DavidBitar,AitorBermejoLópez,youguysmademystayhereinthisdepartmentunforgettable.ThankstomyfriendsinSweden:SonamChokey,Dorji Tshomo,PemaYeshi,AlfPersson,PaulKrusic,NunnapudWilliam Jörgensen, Bo William-Jorgensen and Chatchai Vongpratoom formakingmystayinSwedenmorehomely. Profound appreciation goes tomy uncleDophu and auntDechen Choden fortheir immensesupport,andlove.WithouttheirhelpIwouldnothavemadeitthisfarinmylife.Thankyousomuch.Finally, I would like to thank my mother (Pema Dema) and my late father(Rinzin),theirloveisimmeasurableandtheirsupportsissounthinkablethatishard to express in words. They have providedme not just with the financialmeans, but also with moral and spiritual support, for which I am forevergrateful.TomywifeUma,thankyoudarlingfortheloveandsupport.
61
References
[1] inBaltimoreLecturesonMolecularDynamicsandtheWaveTheoryofLight(Ed.:B.K.W.Thomson),CambridgeUniversityPress,Cambridge,2010,pp.436-467.
[2] A.J.Hutt,J.O'Grady,J.Antimicrob.Chemother.1996,37,7-32.[3] (a)R.Noyori,Angew.Chem.Int.Ed.2002,41,2008-2022;(b)G.-Q.Lin,
J.-G.Zhang,J.-F.Cheng,inChiralDrugs,JohnWiley&Sons,Inc.,2011,pp.3-28.
[4] G.Blaschke,H.P.Kraft,K.Fickentscher,F.Köhler,Arzneimittel-Forschung1979,29,1640-1642.
[5] B.Testa,P.A.Carrupt,J.Gal,Chirality1993,5,105-111.[6] N.Chhabra,M.Aseri,D.Padmanabhan,InternationalJournalofApplied
andBasicMedicalResearch2013,3,16-18.[7] Q.-D.You,inChiralDrugs,JohnWiley&Sons,Inc.,2011,pp.137-194.[8] E.J.J.Grabowski,Chirality2005,17,S249-S259.[9] G.Roos,inKeyChiralAuxiliaryApplications(SecondEdition),Academic
Press,Boston,2014,pp.1-5.[10] Y.Gnas,F.Glorius,Synthesis2006,2006,1899-1930.[11] IUPACCompendiumofChemicalTerminology,
http://goldbook.iupac.org/C00876.html.
[12] V.Caprio,J.M.J.Williams,CatalysisinAsymmetricSynthesis,JohnWiley&Sons,Hoboken,UNITEDSTATES,2009.
[13] G.Shang,W.Li,X.Zhang,inCatalyticAsymmetricSynthesis,JohnWiley&Sons,Inc.,2010,pp.343-436.
[14] H.-J.Federsel,H.U.Blaser,AsymmetricCatalysisonIndustrialScale:Challenges,ApproachesandSolutions,Vol.2nded,Wiley-VCH,Weinheim,2010.
[15] J.F.Young,J.A.Osborn,F.H.Jardine,G.Wilkinson,ChemicalCommunications(London)1965,131-132.
[16] W.S.Knowles,M.J.Sabacky,ChemicalCommunications(London)1968,1445-1446.
[17] L.Horner,H.Siegel,H.Büthe,Angew.Chem.Int.Ed.Engl.1968,7,942-942.
62
[18] W.S.Knowles,M.J.Sabacky,B.D.Vineyard,J.Chem.Soc.,Chem.Commun.1972,10-11.
[19] T.P.Dang,H.B.Kagan,JournaloftheChemicalSocietyD:ChemicalCommunications1971,481-481.
[20] (a)W.S.Knowles,M.J.Sabacky,B.D.Vineyard,D.J.Weinkauff,J.Am.Chem.Soc.1975,97,2567-2568;(b)B.D.Vineyard,W.S.Knowles,M.J.Sabacky,G.L.Bachman,D.J.Weinkauff,J.Am.Chem.Soc.1977,99,5946-5952.
[21] T.Ohta,H.Takaya,R.Noyori,TetrahedronLett.1990,31,7189-7192.[22] R.H.Crabtree,H.Felkin,G.E.Morris,J.Organomet.Chem.1977,141,
205-215.[23] J.R.Shapley,R.R.Schrock,J.A.Osborn,J.Am.Chem.Soc.1969,91,
2816-2817.[24] (a)P.Schnider,G.Koch,R.Prétôt,G.Wang,F.M.Bohnen,C.Krüger,A.
Pfaltz,Chemistry–AEuropeanJournal1997,3,887-892;(b)A.Lightfoot,P.Schnider,A.Pfaltz,Angew.Chem.Int.Ed.1998,37,2897-2899.
[25] J.J.Verendel,O.Pàmies,M.Diéguez,P.G.Andersson,Chem.Rev.2014,114,2130-2169.
[26] R.Dietiker,P.Chen,Angew.Chem.Int.Ed.2004,43,5513-5516.[27] (a)P.Brandt,C.Hedberg,P.G.Andersson,Chemistry–AEuropean
Journal2003,9,339-347;(b)Y.Fan,X.Cui,K.Burgess,M.B.Hall,J.Am.Chem.Soc.2004,126,16688-16689.
[28] S.Gruber,A.Pfaltz,Angew.Chem.Int.Ed.2014,53,1896-1900.[29] T.L.Church,T.Rasmussen,P.G.Andersson,Organometallics2010,29,
6769-6781.[30] A.G.Schultz,Acc.Chem.Res.1990,23,207-213.[31] (a)A.G.Schultz,P.J.McCloskey,J.J.Court,J.Am.Chem.Soc.1987,
109,6493-6502;(b)J.A.Marshall,P.G.M.Wuts,J.Org.Chem.1977,42,1794-1798;(c)J.A.Marshall,P.G.M.Wuts,J.Org.Chem.1978,43,1086-1089;(d)A.G.Schultz,Chem.Commun.1999,1263-1271.
[32] A.G.Schultz,M.A.Holoboski,M.S.Smyth,J.Am.Chem.Soc.1996,118,6210-6219.
[33] SébastienG.,WilfriedR.,XavierB.,ThierryC.,DamienB.,JeanR.,Synthesis2013,45,1909–1930.
[34] A.Paptchikhine,K.Itto,P.G.Andersson,Chem.Commun.2011,47,3989-3991.
[35] P.W.Rabideau,Z.Marcinow,inOrganicReactions,JohnWiley&Sons,Inc.,2004.
[36] (a)H.L.Holmes,inOrganicReactions,JohnWiley&Sons,Inc.,2004;(b)G.Hilt,F.-X.duMesnil,TetrahedronLett.2000,41,6757-6761;(c)N.
63
Akbulut,D.Hartsough,J.I.Kim,G.B.Schuster,J.Org.Chem.1989,54,2549-2556.
[37] A.Hosomi,H.Sakurai,TetrahedronLett.1976,17,1295-1298.[38] (a)S.E.Denmark,J.Fu,Chem.Commun.2003,167-170;(b)C.E.Masse,
J.S.Panek,Chem.Rev.1995,95,1293-1316.[39] (a)E.Langkopf,D.Schinzer,Chem.Rev.1995,95,1375-1408;(b)S.R.
Chemler,W.R.Roush,inModernCarbonylChemistry,Wiley-VCHVerlagGmbH,2007,pp.403-490.
[40] K.Hori,N.Hikage,A.Inagaki,S.Mori,K.Nomura,E.Yoshii,J.Org.Chem.1992,57,2888-2902.
[41] C.H.Heathcock,E.F.Kleinman,E.S.Binkley,J.Am.Chem.Soc.1982,104,1054-1068.
[42] (a)M.Wadamoto,H.Yamamoto,J.Am.Chem.Soc.2005,127,14556-14557;(b)A.Yanagisawa,H.Kageyama,Y.Nakatsuka,K.Asakawa,Y.Matsumoto,H.Yamamoto,Angew.Chem.Int.Ed.1999,38,3701-3703;(c)K.Mikami,S.Matsukawa,TetrahedronLett.1994,35,3133-3136.
[43] (a)M.Sai,H.Yamamoto,J.Am.Chem.Soc.2015,137,7091-7094;(b)D.Kampen,A.Ladépêche,G.Claßen,B.List,Adv.Synth.Catal.2008,350,962-966;(c)N.Momiyama,H.Nishimoto,M.Terada,Org.Lett.2011,13,2126-2129;(d)T.Akiyama,Chem.Rev.2007,107,5744-5758.
[44] (a)J.S.Panek,M.Yang,J.S.Solomon,J.Org.Chem.1993,58,1003-1010;(b)M.E.Maier,B.Schöffling,TetrahedronLetters1990,31,3007-3010;(c)J.D.Sellars,P.G.Steel,M.J.Turner,Chem.Commun.2006,2385-2387.
[45] (a)M.G.Organ,D.D.Winkle,J.Huffmann,J.Org.Chem.1997,62,5254-5266;(b)R.Lauchli,J.M.Whitney,L.Zhu,K.J.Shea,Org.Lett.2005,7,3913-3916;(c)J.W.Han,T.Hayashi,Tetrahedron:Asymmetry2010,21,2193-2197.
[46] P.V.Ramachandran,D.R.Nicponski,P.D.Gagare,inComprehensiveOrganicSynthesisII(SecondEdition),Elsevier,Amsterdam,2014,pp.72-147.
[47] (a)I.Fleming,J.Dunoguès,R.Smithers,inOrganicReactions,JohnWiley&Sons,Inc.,2004;(b)S.E.Denmark,N.G.Almstead,inModernCarbonylChemistry,Wiley-VCHVerlagGmbH,2007,pp.299-401.
[48] (a)J.B.Lambert,R.B.Finzel,J.Am.Chem.Soc.1982,104,2020-2022;(b)S.G.Wierschke,J.Chandrasekhar,W.L.Jorgensen,J.Am.Chem.Soc.1985,107,1496-1500.
[49] C.Gómez,F.F.Huerta,M.Yus,Tetrahedron1997,53,13897-13904.[50] B.K.Peters,J.Liu,C.Margarita,W.Rabten,S.Kerdphon,A.Orebom,T.
Morsch,P.G.Andersson,J.Am.Chem.Soc.2016,138,11930-11935.[51] (a)Y.Zhu,Y.Fan,K.Burgess,J.Am.Chem.Soc.2010,132,6249-6253;
(b)J.-Q.Li,J.Liu,S.Krajangsri,N.Chumnanvej,T.Singh,P.G.
64
Andersson,ACSCatalysis2016,6,8342-8349;(c)J.Liu,S.Krajangsri,T.Singh,G.DeSeriis,N.Chumnanvej,H.Wu,P.G.Andersson,J.Am.Chem.Soc.2017,139,14470-14475.
[52] (a)M.A.Biamonte,inNameReactionsforHomologations,JohnWiley&Sons,Inc.,2009,pp.539-574;(b)L.C.Dias,P.R.R.Meira,Synlett2000,2000,37-40.
[53] H.Sakurai,PureAppl.Chem.1982,54,1-22.[54] H.Deng,D.O'Hagan,C.Schaffrath,NaturalProductReports2004,21,
773-784.[55] (a)T.Hiyama,H.Yamamoto,inOrganofluorineCompounds:Chemistry
andApplications(Ed.:H.Yamamoto),SpringerBerlinHeidelberg,Berlin,Heidelberg,2000,pp.137-182;(b)R.Berger,G.Resnati,P.Metrangolo,E.Weber,J.Hulliger,Chem.Soc.Rev.2011,40,3496-3508;(c)C.Isanbor,D.O’Hagan,J.FluorineChem.2006,127,303-319.
[56] D.O'Hagan,Chem.Soc.Rev.2008,37,308-319.[57] (a)N.M.Kovalchuk,A.Trybala,V.Starov,O.Matar,N.Ivanova,Adv.
ColloidInterfaceSci.2014,210,65-71;(b)B.K.Park,N.R.Kitteringham,P.M.O'Neill,Annu.Rev.Pharmacool.Toxicol.2001,41,443-470;(c)N.A.Meanwell,J.Med.Chem.2011,54,2529-2591.
[58] H.-J.Böhm,D.Banner,S.Bendels,M.Kansy,B.Kuhn,K.Müller,U.Obst-Sander,M.Stahl,ChemBioChem2004,5,637-643.
[59] J.W.Clader,J.Med.Chem.2004,47,1-9.[60] C.D.Cox,P.J.Coleman,M.J.Breslin,D.B.Whitman,R.M.Garbaccio,
M.E.Fraley,C.A.Buser,E.S.Walsh,K.Hamilton,M.D.Schaber,R.B.Lobell,W.Tao,J.P.Davide,R.E.Diehl,M.T.Abrams,V.J.South,H.E.Huber,M.Torrent,T.Prueksaritanont,C.Li,D.E.Slaughter,E.Mahan,C.Fernandez-Metzler,Y.Yan,L.C.Kuo,N.E.Kohl,G.D.Hartman,J.Med.Chem.2008,51,4239-4252.
[61] (a)Z.Ye,G.Zhao,CHIMIAInternationalJournalforChemistry2011,65,902-908;(b)M.C.O’Reilly,C.W.Lindsley,TetrahedronLett.2013,54,3627-3629;(c)Y.Huang,A.M.Walji,C.H.Larsen,D.W.C.MacMillan,J.Am.Chem.Soc.2005,127,15051-15053;(d)S.Zhang,Y.Zhang,Y.Ji,H.Li,W.Wang,Chem.Commun.2009,4886-4888.
[62] (a)Y.Hamashima,K.Yagi,H.Takano,L.Tamás,M.Sodeoka,J.Am.Chem.Soc.2002,124,14530-14531;(b)D.H.Paull,M.T.Scerba,E.Alden-Danforth,L.R.Widger,T.Lectka,J.Am.Chem.Soc.2008,130,17260-17261;(c)M.H.Katcher,A.G.Doyle,J.Am.Chem.Soc.2010,132,17402-17404;(d)J.A.Kalow,A.G.Doyle,J.Am.Chem.Soc.2010,132,3268-3269.
[63] (a)P.Wheeler,H.U.Vora,T.Rovis,ChemicalScience2013,4,1674-1679;(b)F.Li,Z.Wu,J.Wang,Angew.Chem.Int.Ed.2015,54,656-659.
65
[64] M.Saburi,L.Shao,T.Sakurai,Y.Uchida,TetrahedronLett.1992,33,7877-7880.
[65] S.W.Krska,J.V.Mitten,P.G.Dormer,D.Mowrey,F.Machrouhi,Y.Sun,T.D.Nelson,Tetrahedron2009,65,8987-8994.
[66] S.Sano,T.Ando,K.Yokoyama,Y.Nagao,Synlett1998,1998,777-779.[67] S.Sano,R.Teranishi,Y.Nagao,TetrahedronLett.2002,43,9183-9186.[68] H.-J.Tsai,A.Thenappan,D.J.Burton,J.Org.Chem.1994,59,7085-
7091.[69] K.Rousée,J.-P.Bouillon,S.Couve-Bonnaire,X.Pannecoucke,Org.Lett.
2016,18,540-543.[70] M.Engman,J.S.Diesen,A.Paptchikhine,P.G.Andersson,J.Am.Chem.
Soc.2007,129,4536-4537.[71] M.Hudlický,J.FluorineChem.1983,23,241-259.[72] M.Hudlicky,J.FluorineChem.1979,14,189-199.[73] (a)X.Cui,K.Burgess,Chem.Rev.2005,105,3272-3296;(b)S.Kraft,K.
Ryan,R.B.Kargbo,J.Am.Chem.Soc.2017,139,11630-11641;(c)D.H.Woodmansee,A.Pfaltz,Chem.Commun.2011,47,7912-7916.
[74] (a)Y.-Q.Guan,M.Gao,X.Deng,H.Lv,X.Zhang,Chem.Commun.2017,53,8136-8139;(b)S.Song,S.-F.Zhu,Y.Li,Q.-L.Zhou,Org.Lett.2013,15,3722-3725;(c)W.Tang,S.Wu,X.Zhang,J.Am.Chem.Soc.2003,125,9570-9571;(d)Y.-T.Liu,J.-Q.Chen,L.-P.Li,X.-Y.Shao,J.-H.Xie,Q.-L.Zhou,Org.Lett.2017,19,3231-3234.
[75] (a)M.V.Troutman,D.H.Appella,S.L.Buchwald,J.Am.Chem.Soc.1999,121,4916-4917;(b)M.G.Schrems,E.Neumann,A.Pfaltz,Angew.Chem.Int.Ed.2007,46,8274-8276.
[76] X.Dong,W.Yang,W.Hu,J.Sun,Angew.Chem.Int.Ed.2015,54,660-663.
[77] A.Marinetti,H.Jullien,A.Voituriez,Chem.Soc.Rev.2012,41,4884-4908.
[78] (a)B.B.Snider,Acc.Chem.Res.1980,13,426-432;(b)W.Oppolzer,V.Snieckus,Angew.Chem.Int.Ed.Engl.1978,17,476-486.
[79] B.M.Trost,M.Lautens,J.Am.Chem.Soc.1985,107,1781-1783.[80] B.M.Trost,D.C.Lee,F.Rise,TetrahedronLett.1989,30,651-654.[81] B.M.Trost,B.Breit,S.Peukert,J.Zambrano,J.W.Ziller,Angew.Chem.
Int.Ed.Engl.1995,34,2386-2388.[82] (a)A.Goeke,R.Kuwano,Y.Ito,M.Sawamura,Angew.Chem.Int.Ed.
Engl.1996,35,662-663;(b)A.Goeke,M.Sawamura,R.Kuwano,Y.Ito,Angew.Chem.1996,108,686-687.
[83] (a)M.Hatano,M.Terada,K.Mikami,Angew.Chem.Int.Ed.2001,40,249-253;(b)M.Hatano,M.Terada,K.Mikami,Angew.Chem.2001,113,255-259;(c)M.Hatano,K.Mikami,J.Am.Chem.Soc.2003,125,4704-4705.
66
[84] J.Ciesielski,K.Cariou,A.J.Frontier,Org.Lett.2012,14,4082-4085.[85] (a)M.Hatano,K.Mikami,Organic&BiomolecularChemistry2003,1,
3871-3873;(b)M.Hatano,K.Mikami,J.Mol.Catal.A:Chem.2003,196,165-169;(c)M.Hatano,M.Yamanaka,K.Mikami,Eur.J.Org.Chem.2003,2003,2552-2555.
[86] C.Aubert,O.Buisine,M.Malacria,Chem.Rev.2002,102,813-834.[87] B.M.Trost,M.J.Krische,Synlett1998,1998,1-16.[88] (a)K.Mikami,Y.Yusa,M.Hatano,K.Wakabayashi,K.Aikawa,Chem.
Commun.2004,98-99;(b)A.Faulkner,J.S.Scott,J.F.Bower,Chem.Commun.2013,49,1521-1523;(c)J.S.Yadav,T.V.Pratap,V.Rajender,J.Org.Chem.2007,72,5882-5885;(d)A.V.Malkov,L.Czemerys,D.A.Malyshev,J.Org.Chem.2009,74,3350-3355;(e)H.S.Dang,A.G.Davies,I.G.E.Davison,C.H.Schiesser,J.Org.Chem.1990,55,1432-1438;(f)T.Matsuda,Y.Sakurai,J.Org.Chem.2014,79,2739-2745;(g)M.J.Mitton-Fry,A.J.Cullen,T.Sammakia,Angew.Chem.Int.Ed.2007,46,1066-1070.
[89] (a)M.Engman,P.Cheruku,P.Tolstoy,J.Bergquist,S.F.Völker,P.G.Andersson,Adv.Synth.Catal.2009,351,375-378;(b)P.Kaukoranta,M.Engman,C.Hedberg,J.Bergquist,P.G.Andersson,Adv.Synth.Catal.2008,350,1168-1176;(c)P.Cheruku,A.Paptchikhine,M.Ali,J.-M.Neudorfl,P.G.Andersson,Organic&BiomolecularChemistry2008,6,366-373;(d)J.J.Verendel,T.Zhou,J.-Q.Li,A.Paptchikhine,O.Lebedev,P.G.Andersson,J.Am.Chem.Soc.2010,132,8880-8881;(e)T.Zhou,B.Peters,M.F.Maldonado,T.Govender,P.G.Andersson,J.Am.Chem.Soc.2012,134,13592-13595;(f)J.J.Verendel,J.-Q.Li,X.Quan,B.Peters,T.Zhou,O.R.Gautun,T.Govender,P.G.Andersson,Chemistry–AEuropeanJournal2012,18,6507-6513.